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Abbreviations 
 
Aa   Amino acid 
ABD   Actin-binding domains 
cDNA   Complementary DNA 
CH   Calponin homology 
Co-IP   Co-Immunoprecipitation 
Da   Dalton 
DAPI   4’-6-diamidino-2-phenylindole 
DMEM  Dulbecco`s modified Eagle medium 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
dNTP   Deoxynucleoside triphosphate 
DTT   Dithiothreitol 
EDTA   Ethylene diamine tetraacetic acid 
ECL   Enhanced chemiluminescence 
EDMD  Emery Dreifuss Muscular Dystrophy 
F-actin  Filamentous actin 
FBS   Fetal bovine serum 
GAPDH  Glycerinaldehydephosphate dehydrogenase 
GFP   Green fluorescent protein 
GST   Glutathione S-transferase 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HGPS           Hutchinson-Gilford progeria syndrome 
IgG   Immunglobulin G 
IPTG   Isopropyl-β-Dithiogalactopyranoside 
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IF          Immunofluorescence 
IP   Immunoprecipitation 
KASH   Klarsicht, ANC1 and SYNE1 homology 
KD   Knock down 
KO   Knock out 
mRNA  messenger ribonucleic acid 
MS   Mass spectrometry 
Nesprins  Nuclear envelope spectrin repeat proteins 
NPC   Nuclear pore complex 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PFA           Paraformaldehyde 
pH   negative decadic logarithm of protein concentration 
PIC   Proteinase inhibitor cocktail 
rpm   Rotation per minute 
qRT-PCR  Quantitative real time PCR 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
shRNA  Short hairpin RNA 
SR   Spectrin repeats 
SUN   Sad1 and UNC-84 
TBS   Tris buffered saline 
UV            Ultraviolet light 
WB   Western blot 
WT   Wild type  
X-gal   5-bromo-4-chloro-3-indolyl-D-galactopyranosid 
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Summary  
Nuclear envelope (NE) proteins have fundamental roles in maintaining nuclear 
structure, cell signaling, chromatin organization and gene regulation, and mutations 
in genes encoding NE components were identified as primary cause of a number of 
age associated diseases and cancer. Nesprin-1 belongs to a family of multi-isomeric 
NE proteins that are characterized by spectrin repeats. Our results imply interactions 
between spectrin repeats and an interaction of Nesprin-1 with Nesprin-2. 
Furthermore, we analysed NE components in various tumor cell lines and found that 
Nesprin-1 levels were strongly reduced associated with alterations in further NE 
components. By reducing the amounts of Nesprin-1 by RNAi mediated knock down 
we could reproduce those alterations in mouse and human cell lines pointing towards 
a key role for Nesprin-1 in the maintenance of nucleus morphology, centrosome 
positioning, nuclear membrane structure, cytoskeleton organization, and cellular 
senescence. In a search for novel Nesprin-1 binding proteins we identified MSH2, 
MSH6, and DDB1 proteins of the DNA damage response pathway as interactors. We 
found alterations in the mismatch repair pathway in cells with lower Nesprin-1 levels. 
We also noticed an increased number of γH2AX foci in the absence of exogenous 
DNA damage as was seen in tumor cells. The levels of phosphorylated kinases Chk1 
and 2 were altered in a manner resembling tumor cells and the levels of Ku70 were 
low and the protein was not recruited to the DNA after HU treatment. Our findings 
indicate a role for Nesprin-1 in the DNA damage response pathway and propose 
Nesprin-1 as novel regulator of tumorigenesis and genome instability. Loss of 
Nesprin-1 might play a significant role in cancer progression. 
 
Zusammenfassung 
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Zusammenfassung 
Kernhüllenproteine haben eine wesentliche Rolle bei der Aufrechterhaltung der 
Kernstruktur, Chromatinorganisation, Genregulation und bei 
Signaltransduktionsprozessen, und Mutationen in Genen, die für 
Kernhüllenkomponenten kodieren, wurden als primäre Ursache für eine Reihe von 
Erkrankungen und Krebs identifiziert. Nesprin-1 gehört zu einer Familie von multi-
isomeren Proteinen der Kernhülle, die von Spectrin Wiederholungen gekennzeichnet 
sind. Unsere Ergebnisse zeigen, dass Nesprin-1 mit Nesprin-2 über 
Wechselwirkungen ihrer Spectrin Repeats miteinander interagieren. Weiterhin haben 
wir die Kernhüllenkomponenten in verschiedenen Tumor-Zelllinien analysiert und 
dabei festgestellt, dass die Nesprin-1-Spiegel stark reduziert und mit Veränderungen 
in weiteren Kernhüllenproteinen und anderen Kern-assoziierten Prozessen 
verbunden waren. Durch die Reduzierung der Mengen an Nesprin-1 durch einen 
RNAi-vermittelten Knockdown konnten wir diese Veränderungen in murinen und 
humanen Zelllinien reproduzieren. Diese Ergebnisse verweisen auf eine 
Schlüsselrolle für Nesprin-1 bei der Aufrechterhaltung der Kernmorphologie, 
Zentrosomenpositionierung, Struktur der Kernmembran, Organisation des 
Cytoskeletts und der zellulären Seneszenz. Bei der Suche nach neuen Nesprin-1-
bindenden Proteinen identifizierten wir MSH2, MSH6 und DDB1 als 
Interaktionspartner, die Proteine von DNA-Reparaturwegen sind. In 
Übereinstimmung damit haben wir Veränderungen im Mismatch-Reparaturweg in 
Zellen mit niedrigen Nesprin-1-Spiegeln beobachtet. Wir haben auch eine erhöhte 
Anzahl von γH2AX Foci in Abwesenheit von exogenen DNA-Schäden festgestellt, 
wie es in Tumorzellen gesehen wird. Die Mengen der phosphorylierten Kinasen Chk1 
und 2, die an Kontrollpunkten im Zellzyklus auftreten, waren in einer ähnlichen Weise 
Zusammenfassung 
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in Tumorzellen verändert und die Mengen an Ku70 waren niedrig und das Protein 
wurde nicht an die DNA nach HU Behandlung rekrutiert. Unsere Ergebnisse zeigen 
eine Rolle für Nesprin-1 im DNA-Reparaturweg und schlagen Nesprin-1 als 
neuartigen Regulator für Tumorentstehung und Genominstabilität vor. Der Verlust 
von Nesprin-1 könnte eine wichtige Rolle in der Tumorprogression spielen. 
Introduction 
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1. Introduction 
1.1 Nuclear envelope and LINC complex 
The genome is contained within the nucleus in eukaryotic cells and is separated from 
the cytoplasm by a selective barrier, the nuclear envelope (NE). The proteins of the 
NE regulate the nucleo-cytoplasmic traffic and connect the nucleoplasm to the 
cytoplasm (Maraldi et al., 2010; Shimi et al., 2012). The NE consists of an outer 
(ONM) and inner nuclear membrane (INM) which enclose the perinuclear space 
(PNS). The ONM is contiguous with the endoplasmic reticulum, the INM contacts the 
nuclear lamina and chromatin (Figure 1). 
 
 
Figure 1: The structure of the nuclear envelope (NE). The NE is a barrier 
separating the nucleus from the cytoplasm and consists of ONM and INM, nuclear 
pore complexes (NPC), proteins of the INM, ONM, lamins and other proteins. ABD: 
Actin-binding domain; PBD: Plectin-binding domain. This model was taken from the 
lab website of Dr. Didier Hodzic. The question mark points out unknown functions of 
these connections. 
 
Nuclear pore complexes (NPC) are inserted into the NE and connect the nucleus with 
the cytoplasm. The protein composition of the NE is complex as more than 100 
Introduction 
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proteins have been described and differs between the ONM and INM (Schirmer et al., 
2003). The NE proteins are involved in a variety of cellular processes including 
genome organization, gene expression and stability (Therizols et al., 2006; Chow et 
al., 2012). 
An important component of the NE is the LINC (linker of nucleoskeleton and 
cytoskeleton) complex which connects the nucleus with the cytoskeleton. The LINC 
complex is present in a wide variety of organisms including amoebae, yeast, worms, 
flies, vertebrates, and plants (Schneider et al., 2008; Schulz et al., 2009; Graumann 
and Evans, 2010; Starr and Fridolfsson, 2010). The central components of 
mammalian LINC complexes are SUN (Sad1p, UNC-84) domain proteins and KASH-
domain containing proteins, the Nesprins (Nuclear envelope spectrin repeats), which 
connect to Emerin, Lamins and chromatin at the nucleoplasmic side and to F-actin, 
microtubules, intermediate filaments and plectin at the cytoplasmic side (Figure 1) 
(Padmakumar et al., 2005; Crisp et al., 2006). 
 
1.1.1 INM components of LINC complexes, and their functions 
Among the first INM components recognized were members of the LEM domain 
family of proteins, which are named for the founding members, LAP2, Emerin and 
MAN1 (Figure 2) (Hetzer et al., 2005). The LEM domain is composed of a motif of 
approximately 40 amino acids that mediates binding to BAF (barrier-to-
autointegration factor) which is an abundant chromatin-associated protein (Lin et al., 
2000; Laguri et al., 2001; Shumaker et al., 2001). LAP2 (lamina associated 
polypeptides 2), one of the LEM domain proteins, has several isoforms in mammals 
(Berger et al., 1996). Specifically, LAP2β is the most ubiquitous LAP2 isoform and 
interacts with chromatin and Lamin B via a specific region at its C-terminus. 
Introduction 
 3 
Emerin is a 254 amino acid protein and has an N-terminal LEM-domain. It was the 
first NE protein which was linked to a human disease, Emery-Dreifuss muscular 
dystrophy (Bione et al., 1994) and is involved in several protein–protein interactions 
(Cartegni et al., 1997; Squarzoni et al., 1998; Liu et al., 2003). Emerin plays key roles 
in signal transduction, chromatin organization and gene expression. Additionally, 
Emerin links centrosomes to the nuclear envelope via a microtubule association 
(Holaska et al., 2004; Markiewicz et al., 2006; Salpingidou et al., 2007). 
 
 
Figure 2: Illustration of LEM interactions. Emerin is anchored at the INM and 
interacts with lamin A, GCL (germ-cell-less), BAF, actin and a Nesprin-1α dimer. The 
seven SR domains in Nesprin-1α are numbered 1–7, beginning at the N-terminus. 
The image is not drawn to scale (Bengtsson and Wilson, 2004). 
 
LEM domain proteins have also been linked to nuclear shape (Lammerding et al., 
2005) and transcriptional regulation (Nili et al., 2001) as well as signaling cascades 
(Pan et al., 2005; Markiewicz et al., 2006). 
Introduction 
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The nuclear lamina underneath the INM is a network of type V intermediate filaments, 
and subdivided to A- and B-type lamins (Gerace et al., 1978; McKeon et al., 1986). 
All A-type Lamins, A, AΔ10, C, and C2 are encoded by the LMNA gene (Worman and 
Bonne, 2007). By contrast, B-type Lamins 1 and 2 are encoded by LMNB1 and 
LMNB2, respectively (Worman and Bonne, 2007). B-type LaminB3 is a splice variant 
of the LMNB2 gene (Furukawa and Hotta, 1993). Several studies suggested that 
Lamins participate in functions ranging from nuclear shape and stability to replication, 
transcription and splicing (Moir et al., 2000; Schirmer et al., 2001; Kumaran et al., 
2002; Lammerding et al., 2004). 
SUN proteins are prototypical type-II transmembrane proteins of the INM 
components of the LINC complex with their N-terminus facing the nucleoplasm, and a 
C-terminal conserved SUN domain localizing in the perinuclear space (PNS) between 
the INM and ONM. At the nuclear side they interact with Lamins (Padmakumar et al., 
2005; Crisp et al., 2006; Haque et al., 2006). To date, five SUN proteins have been 
identified; SUN1 (UNC-84A), SUN2 (UNC-84B), SUN3, SUN4 (SPAG4), and SUN5 
(SPAG4L). Remarkably, SUN proteins play important roles in genome stability and 
nucleus centrosome coupling (Zhang et al., 2009; Lei et al., 2012). 
 
1.1.2 Nesprins, ONM components of LINC complexes and their functions 
Nesprins are type II transmembrane proteins, which connect the nucleus with the 
cytoskeleton. Nesprins localize to both nuclear membranes and have evolutionarily 
conserved orthologs in lower organisms including Schizosaccharomyces pombe 
(Kms1), Dictyostelium discoideum (interaptin), Caenorhabditis elegans (ANC-1, ZYG-
12 and UNC-83), and Drosophila melanogaster (Msp-300). To date, four Nesprins 
have been described (Nesprin-1, Nesprin-2, Nesprin-3, Nesprin-4). They are 
Introduction 
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encoded by separate genes (SYNE1, SYNE2, SYNE3, SYNE4) that give rise to 
multiple isoforms (Figure 3.1). Nesprins have a varying number of SR domains, each 
of which consists of approximately 106 residues that form a triple-helical bundle. SR 
domains facilitate protein-protein interactions, crosslink actin and microtubules, and 
function as molecular scaffolds or stabilizers (Rajgor et al., 2012). 
The giant isoforms of Nesprin-1 (1 MDa) and Nesprin-2 (800 kDa) are greatly 
homologous to one another and share an N-terminal actin-binding domain (ABD) 
made from two calponin homology domains thereby linking the NE to the actin 
cytoskeleton (Zhen et al., 2002; Padmakumar et al., 2004). On the other hand, 
Nesprin-1 and Nesprin-2 can bind to microtubule motor proteins, kinesin and dynein, 
through specific spectrin repeats (Zhang et al., 2009; Schneider et al., 2011b; Yu et 
al., 2011). Nesprin-3 and Nesprin-4 are much smaller and lack N terminal ABDs. 
Nesprin-3 interacts with plectin which provides a link to the intermediate filament 
system, Nesprin-4 can associate with kinesin-1 which establishes a link to 
microtubules (Wilhelmsen et al., 2005; Roux et al., 2009). In the LINC complex, 
Nesprins bind through their C-terminal luminal amino acids to the C-terminal SUN 
domain of SUN proteins. The structure of this complex has been recently solved and 
the presence of a trimer revealed (Sosa et al., 2012; Wang et al., 2012; Rothballer et 
al., 2013).  
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Figure 3.1: Scheme of Nesprin isoforms. Nesprins share common structural 
features, a N-terminal calponin homology (CH) domain (yellow) and a C-terminal 
KASH domain (red) and a spectrin repeat containing rod (blue). Each Nesprin is 
encoded by a single gene that gives rise to many different isoforms. This Figure was 
taken from (Rajgor et al., 2012) and modified. 
 
On the other hand, Nesprins can form self-interactions via their SRs and the ABD of 
Nesprin-1 and Nesprin-2 was shown to interact with N-terminal spectrin repeats of 
Introduction 
 7 
Nesprin-3 (Mislow et al., 2002a; Lu et al., 2012; Taranum et al., 2012a). Based on 
these binding abilities, Nesprins enable a more orchestrated protein network along 
the nuclear envelope (Figure 3.2). 
 
 
Figure 3.2: Schematic diagram of Nesprin interactions at the outer nuclear 
membrane surface. Nesprins form self-interactions via their SRs. The ABDs of 
Nesprin-1/-2 interact with F-actin, N-terminal Nesprin-1 spectrin repeats interact with 
Nesprin-3 (modified from (Taranum et al., 2012a)). 
 
Due to the establishment of nuclear-cytoskeletal connections, Nesprins play key roles 
in biologically important functions and this is supported by several studies (Table 1). 
Especially, Nesprin-1 and Nesprin-2 contribute to nuclear shape and position of the 
nucleus (Grady et al., 2005; Zhang et al., 2005; Kandert et al., 2007; Luke et al., 
2008; Puckelwartz et al., 2009). A recent report also indicated that Nesprin-3 
regulates cell morphology and cell migration (Morgan et al., 2011; Khatau et al., 
2012). On the other hand, in Nesprin-4 knock out (KO) mice, nuclear position was 
changed in outer hair cells, thereby leading to hear loss (Horn et al., 2013). More 
recently, the effects of Nesprin-1, Nesprin-2, and Nesprin-3 on centrosome 
positioning have been reported (Zhang et al., 2009; Morgan et al., 2011).  
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Table 1: Interactions of Nesprins with cellular components and functions of 
these connections. Nesprins have key roles in many aspects of cell functions due to 
their nuclear-cytoskeletal connections (modified from (Mellad et al., 2011)). 
 
Connection Nesprin Function 
Actin   F-actin Nesprin-1  Nuclear positioning, 
     Nesprin-2  Mechanotransduction 
   Meckelin Nesprin-2  Ciliogenesis 
IF   Lamin A Nesprin1/2  Chromatin organization, 
        NE architecture 
   Plectin Nesprin-3  NE-IF coupling 
Microtubules  Kinesin-1 Nesprin-2/4  Nuclear migration, polarity 
   Kinesin-2 Nesprin-1  Vesicular transport 
   Dynein Nesprin-1/2  Nuclear migration, polarity 
   Dynactin Nesprin-1/2  Nuclear migration, polarity 
 
1.1.3 Nesprin-1 
The human Nesprin-1 locus (SYNE1) at chromosome position 6q25 has 147 exons 
that encode up to 8,797 residues (Padmakumar et al., 2004). Nesprin-1 is a ~1 MDa 
protein with 74 predicted spectrin repeats (Figure 3.1). There are several isoforms for 
Nesprin-1 with many names including Syne-1 (Apel et al., 2000), Drop1 (Marme et 
al., 2008), GSRP56 (Kobayashi et al., 2006), MSP300 (Rosenberg-Hasson et al., 
1996), Myne-1 (Mislow et al., 2002b), Enaptin (Padmakumar et al., 2004), CPG2 
(Nedivi et al., 1996), ANC-1 (Starr and Han, 2002). One of the small isoforms, 
Nesprin-1α, localizes at the nuclear inner membrane and interacts with Emerin and 
Lamin A (Mislow et al., 2002a). The longest Nesprin-1 isoforms contain the ABD 
motif at their N-terminus, which colocalizes with F-actin in vivo (Starr and Han, 2002; 
Introduction 
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Padmakumar et al., 2004) and a highly conserved KASH domain at their C-terminus 
(Zhang et al., 2002). Nesprin-1-165 harbors the ABD and the first 11 spectrin 
repeats, CPG2 contains spectrin repeats 3 to 11.  
In several cell lines, Nesprin-1 isoforms are localized to the nucleolus, to 
microtubules, stress-fibres, focal adhesions, and RNA processing bodies. It is 
important to note that the localization of individual Nesprin-1 isoforms can vary 
depending on which cell types express them, suggesting that any single Nesprin-1 
isoform may have different functions in different cell lines. Beyond that, Nesprin-1 
isoforms anchor to the Golgi apparatus and to mitochondria and overexpression of 
the Golgi-binding domain of Nesprin-1 causes the Golgi to collapse into a condensed 
structure near the centrosome (Gough et al., 2003). Moreover, Nesprin-1 has been 
reported to localize to the Golgi apparatus and over-expression of dominant-negative 
Nesprin-1 fragments composed of SRs within the central rod domain disrupt Golgi 
organization and function (Gough et al., 2003; Gough and Beck, 2004; Kobayashi et 
al., 2006). The candidate plasticity gene 2 (cpg2), brain-specific Nesprin-1 isoform, 
encompasses solely SRs and localizes to the neuronal postsynaptic endocytic zone 
surrounding dendritic spines where it regulates clathrin-mediated uptake and 
recycling of chemokine receptors (Nedivi et al., 1996; Cottrell et al., 2004). 
Analysis of Nesprin-1 KO mice strongly indicate the importance of Nesprin-1 for 
nuclear morphology, NE organization, actin organization and cell motility (Grady et 
al., 2005; Zhang et al., 2007; Chancellor et al., 2010; Zhang et al., 2010), and in vitro 
studies demonstrated that knock down of Nesprin-1 led to nuclear defects and 
mislocalization of Emerin and SUN2 in U20S and fibroblast cells (Zhang et al., 2007). 
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1.2 The LINC complex in human diseases and its cancer 
connections 
Disruption of the nuclear-cytoskeletal connection has severe consequences: The 
stability, size and shape of the nucleus are altered, its position in the cell is disturbed, 
cell migration is affected, the mechanical properties of the cell and 
mechanotransduction from the extracellular space to the nucleus are impaired as well 
as signaling processes. The importance of the LINC complex is further underlined by 
the large group of diseases in which components of the LINC complex are mutated 
generating a variety of degenerative diseases affecting striated muscle and 
peripheral nerves, skeletal and fat development, and premature aging syndromes 
(Zaremba-Czogalla et al., 2011). 
Disruption of the LINC complex via mutations in the genes encoding Nesprin-1 and 
Nesprin-2 or their binding partners such as Emerin and Lamin A/C gives rise to 
Emery-Dreifuss Muscular Dystrophy (EDMD) (Table 2). Other mutations in LMNA 
cause Hutchinson Gilford progeria syndrome (HGPS) or Charcot-Marie-Tooth (CMT) 
disorder and many other syndromes (Zaremba-Czogalla et al., 2011). Mutations in 
SYNE1 in addition to being responsible for some forms of Emery-Dreifuss muscular 
dystrophy cause cerebellar ataxia and arthrogryposis (Gros-Louis et al., 2007; Zhang 
et al., 2007; Attali et al., 2009). To date, more than 300 mutations in ten genes 
encoding proteins of the NE have been linked with laminopathies (Mejat and Misteli, 
2010). 
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Table 2: Diseases caused by gene mutations in NE proteins. This table 
summarizes mutated genes and the resulting diseases. LMNA (A-type lamins), 
LMNB1 (lamin B1), LMNB2 (lamin B2), EDMD (emerin), SYNE1 (Nesprin-1), SYNE2 
(Nesprin-2), TMEM43 (transmembrane protein 43), TMPO (thymopoietin), 
ZMPSTE24 (zinc metallopeptidase STE24), BANF1 (barrier to autointegration factor 
1), LEMD3 (MAN1), LBR (lamin B receptor) (taken from (Schreiber and Kennedy, 
2013)). 
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During tumor formation several cellular activities are deregulated. This includes cell 
motility, adhesion, proliferation, metabolism and DNA damage response. Many of 
these features depend on the integrity and organization of NE and morphological 
changes of the NE and LINC complex are a hallmark of cancer. Although much of the 
emphasis has been on deciphering the aetiology of these specific and often 
devastating diseases, recent studies also shed new light on how cancer associated 
alterations of LINC complex protein expression levels may affect tumorigenesis and 
provide an informative parameter in tumor detection and characterization.  
Several components of the LINC complex, Lamins (Broers et al., 1993; Moss et al., 
1999), LAP2 (Somech et al., 2007), and Emerin (Capo-chichi et al., 2009) were 
discovered as biomarkers in a wide range of cancer types (Table 3). Interestingly, not 
only was mRNA encoding lamin B1 found in the blood circulation (Sun et al., 2010), 
and its detection in plasma indicate early stage hepatocellular carcinoma, but lamin 
B1 was also in a proteomic approach found to be upregulated in hepatocellular 
tumors (Lim et al., 2002). On the other hand, the nucleoporin NUP88 has been 
assessed as a cancer biomarker (Martinez et al., 1999) and was found in several 
studies to be overexpressed in malignant tissues (Gould et al., 2002; Agudo et al., 
2004; Knoess et al., 2006; Brustmann and Hager, 2009; Schneider et al., 2010). 
Down regulation of Drop1, an N-terminal isoform of Nesprin-1, has been observed in 
early tumor stages in a wide range of human carcinomas and may play a role in 
chromatin organization (Raffaele Di Barletta et al., 2000; Dou et al., 2005; Marme et 
al., 2008). Furthermore, mutations in SYNE1 were observed in ovarian and colorectal 
cancers (Sjoblom et al., 2006; Doherty et al., 2010). Additionally, the SYNE1 gene 
was frequently methylated in lung cancer cell lines, lung adenocarcinoma (Tessema 
et al., 2008) and colorectal cancer (Schuebel et al., 2007). By bioinformatic analysis 
of data from a collection of cancer genome samples Mascia and Karchin identified 
Introduction 
 13 
SYNE1 as one of the genes that participated in glioblastoma progression (Masica 
and Karchin, 2011). They observed that mutations in SYNE1 were associated with a 
large number of differentially expressed genes. 
 
Table 3: Nuclear envelope components and tumorigenesis. The table 
summarizes cancer-associated alterations in the nuclear envelope components 
(modified from (Chow et al., 2012)). 
 
 
 
Introduction 
 14 
1.3 DNA repair pathways and mechanisms 
Biologically, nuclear DNA is the most important component in the cell since it has all 
the genetic information required for proper cell functions. It is well known that 
mutagenic compounds, ionizing radiation, oxidative stress, and also normal DNA 
metabolic activities like replication and recombination can cause alterations in the 
DNA. It is therefore not surprising that any damage that leads to a break in the DNA 
double helix triggers a quick cellular reaction.  
To maintain genetic stability and relay genetic information from one cell to another, 
mechanisms are required to protect the DNA against the accumulation of DNA 
damage. These mechanisms have been defined as DNA repair pathways. The major 
DNA repair pathways are non-homologous end-joining (NHEJ), nucleotide excision 
repair (NER), mismatch repair (MMR), homologous recombination (HR), and base 
excision repair (BER) (Figure 4). 
 
 
Figure 4: DNA repair pathways. Non-homologous end-joining (NHEJ), nucleotide 
excision repair (NER), mismatch repair (MMR), homologous recombination (HR), and 
base excision repair (BER) are the major DNA repair pathways (Melis et al., 2011). 
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More importantly, defects in DNA repair pathways lead to genome instability, 
tumorigenesis, and aging owing to accumulative DNA damage (de Boer and 
Hoeijmakers, 2000). 
 
1.3.1 Non-homologous end-joining (NHEJ) pathway 
One of the most dangerous forms of DNA damage is the DNA double-strand breaks 
(DSBs), which can result in genome instability if not repaired successfully (Hartlerode 
and Scully, 2009). DSBs initiate signalling cascades that trigger cell cycle 
checkpoints and change gene transcription to maintain genome stability (Valerie and 
Povirk, 2003; Cann and Hicks, 2007). 
There are two main signalling networks in eukaryotic cells to repair DSBs: 
homologous recombination (HR) and nonhomologous end-joining (NHEJ) (Figure 5). 
A recent report indicated that HR uses a homologous chromosome or sister 
chromatid as template to repair the broken DNA and NHEJ re-ligates the two broken 
DNA ends together (Cann and Hicks, 2007). Based on this the NHEJ is an error-
prone repair mechanism that might cause insertion and deletion of DNA sequences. 
The DDR pathway is initiated by a phosphorylation cascade that triggers chromatin 
modifications which improve accessibility of the broken DNA to repair complexes and 
promotes the subsequent accumulation of DDR complexes into lesions at the site of 
damage (Riches et al., 2008). Ataxia telangiectasia mutated (ATM)-mediated 
phosphorylation of the histone variant H2AX is the initial step to create a platform to 
which other DDR complexes are able to bind (Marti et al., 2006). ATM triggers 
signaling cascades that activate cell cycle checkpoints leading to cell cycle arrest 
through phosphorylation of several proteins including CHK1, CHK2, p53, MDC1, and 
BRCA1 (Lavin and Kozlov, 2007). 
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Figure 5: Overview of DNA DSBs repair pathways. DSBs in the DNA are induced 
by damaging agents. Phosphorylation of histone H2AX (γH2AX) is the initial step of 
these pathways. In the NHEJ pathway, the two broken ends are bound by the DNA-
end-binding protein Ku, which recruits the DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) to the free DNA ends. Homologous recombination requires 
BRCA1, RAD51 (which forms filaments along the unwound DNA strand to facilitate 
strand invasions) and RAD52 (a DNA-end-binding protein) (modified from 
(Chowdhury et al., 2013)). 
 
Ku is the DNA-binding component of the NHEJ repair machinery. Ku recruits DNA-
PKcs to form the active protein kinase complex DNA-PK upon recognition and 
binding to the broken DNA end (Mahaney et al., 2009). Following this process, Ku 
appears to protect broken DNA from nuclease binding or activity (Downs and 
Jackson, 2004). In addition, Ku has also been shown to bind to telomeres and to 
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function in telomere maintenance, remarkably by anchoring telomeres to the nuclear 
periphery, thus contributing to telomeric silencing and preventing telomere shortening 
(Riha et al., 2006).  
Sharpless et al. carried out a study which indicated that NHEJ-deficiency predisposes 
to cancer (Sharpless et al., 2001). Moreover, mice lacking p53, DNA-PKcs or Ku80 
succumb in early postnatal life to progenitor B cell lymphomas (Guidos et al., 1996; 
Nacht et al., 1996; Difilippantonio et al., 2000; Lim et al., 2000).  
 
1.3.2 Nucleotide excision repair 
The nucleotide excision repair (NER) pathway is characterized by the removal of 
bulky DNA helix-distorting injuries of both exogenous and endogenous origin. These 
helix-distorting DNA lesions recruit the proteins of this pathway to the damaged DNA 
sites (Figure 6). 
GG-NER (global genomic repair) and TC-NER (transcription-coupled repair) are two 
subpathways of NER (Bohr et al., 1985; Mellon et al., 1987). GG-NER is independent 
of transcription and is constantly screening the genome for the identification of 
distorting lesions in the DNA helix, whereas TC-NER is recruited to the transcribed 
DNA strand of active genes to repair transcription blocking lesions (Yasuda et al., 
2007). About 30 proteins participate in the NER pathway, most function in GG-NER 
as well as in TC-NER (Christmann et al., 2003). However, they have different types 
of damage recognition and therefore contain different proteins that recognize the 
damage.  
Introduction 
 18 
 
Figure 6: NER repairs UV-induced pyrimidine dimers, protein-DNA and intra-
strand crosslinks, and a wide range of bulky chemical adducts. Global GG-NER 
and TC-NER differ in their damage recognition. In GG-NER, damage recognition is 
accomplished by the XPC-HR23B protein complex whereas CSA and CSB proteins 
are responsible for the initial detection of damaged DNA in TC-NER (Melis et al., 
2011). 
 
GG-NER uses the XPC-HR23B protein complex as the primary recognition factor 
(Volker et al., 2001; Hanawalt, 2002). Recently, it has been reported that, for certain 
types of lesions, different proteins are responsible for the initial recognition. 
Additionally, DDB2 (or XPE) bound to DDB1 can recognise CPD lesions. The XPE-
DDB1 complex recruits the XPC-HR23B complex to the lesion, where it gets 
exchanged by the XPC-HR23B complex and repair takes place (Kulaksiz et al., 
2005). In TC-NER, DNA damage is recognized by CSA and CSB proteins. After 
recognition, these proteins bind to the DNA lesion thereby distorting the DNA and 
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recruiting other factors of this repair system to reproduce the correct DNA sequence 
(Gillet and Scharer, 2006; Trego and Turchi, 2006).  
Although somatic alterations in some of the NER factors lead to skin cancer, defects 
in the NER pathway associate with genetic disorders such as the Xeroderma 
pigmentosum (XP) syndrome (Yasuda et al., 2007). 
 
1.3.3 Mismatch repair network 
The mismatch repair (MMR) is a conserved biological pathway from bacteria to man 
that plays a critical role in maintaining genome stability. Its function is in correcting 
DNA mismatches occurred during DNA replication to prevent mutations in dividing 
cells. MMR is also required for damage-induced cell cycle checkpoint response. 
Deficiency of MMR activity causes replication-associated errors leading to point and 
frameshift mutations and tumorigenesis (Jacob and Praz, 2002). 
The initial step in MMR is identification of the mispaired region (Figure 8). Two 
separate heterodimers known as MutSα (Msh2/Msh6 in eukaryotes) (Iaccarino et al., 
1996), and MutSβ (Msh2/Msh3) participate in this process (Habraken et al., 1996; 
Palombo et al., 1996). MutS is a DNA‐binding protein, contains an ATPase domain 
and a protein‐protein interaction domain that allows two MutS molecules to interact in 
order to form dimers (Lamers et al., 2000; Obmolova et al., 2000). While MutSα binds 
primarily to single-base pair mismatches and small insertion/deletion loops, MutSβ 
binds to larger insertion/deletion loops (Acharya et al., 1996; Marsischky et al., 1996). 
After mismatch recognition, MutL homologs are responsible to repair mismatches. At 
least 4 human MutL homologs, hMLH1, hMLH3, hPMS1, and hPMS2 have been 
identified (Bronner et al., 1994; Nicolaides et al., 1994; Papadopoulos et al., 1994; 
Lipkin et al., 2000). 
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Figure 7: Mismatch repair. MSH2–MSH6 and PMSH2-MLH1 heterodimers bind to 
single base pair mismatches in an ATP-dependent manner. The lesion is digested by 
EXO1, and then filled in by DNA polymerases. Question mark points out the unknown 
homologue of prokaryote MutH in eukaryotes (Martin and Scharff, 2002). 
 
hMLH1 heterodimerizes with hPMS2, hPMS1, or hMLH3 to form hMutLα, hMutLβ, or 
hMutLγ, respectively (Kunkel and Erie, 2005). MutLα heterodimer (Mlh1/Pms1) 
initiates subsequent repair events (Prolla et al., 1994; Pang et al., 1997). hMutLα is 
required for MMR and hMutLγ plays a role in meiosis, but no specific biological role 
has been identified for hMutLβ (Kunkel and Erie, 2005). hMutLα possesses an 
ATPase activity and defects in this activity inactivate MMR in human cells. Defects in 
the MMR pathway have been associated with a number of different malignancies 
(Gazzoli et al., 2002).  
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1.4 Aim of the project 
Goal of this study is to provide a picture of the interactions and roles of Nesprin-1. 
This will allow defining its roles in health and disease more precisely and will provide 
mechanisms underlying these roles. We will specifically try  
1. to understand the role of Nesprin-1 in tumorigenesis and genome stability 
2. to identify possible interaction partners of Nesprin-1 
3. to detect consequences of Nesprin-1 loss 
4. to elucidate the role of Nesprin-1 in DDR and DNA repair pathways. 
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2. Results 
2.1 Nesprin-1 interactions 
2.1.1 Interactions of N-terminal Nesprin-1 spectrin repeats  
Earlier studies have demonstrated that the C-terminal isoform Nesprin-1α can self-
associate through its third and fifth spectrin repeat to form an antiparallel dimer 
(Mislow et al., 2002a; Zhong et al., 2010). Whether other spectrin repeats of Nesprin-
1, in particular the N-terminal spectrin repeats, possess similar oligomerization 
properties is not known. When we compared Nesprin-1’s N-terminal spectrin repeats 
to the spectrin repeats of mouse α-actinin 2, SR1, 2, and 4 showed homology with 
SR2 from α-actinin, and SR10 and 11 resembled SR1 and SR4, respectively. The 
remaining SRs exhibited less homology with the ones of α-actinin. From earlier 
reports it is known that spectrin repeats of the α-actinin type can dimerize as in α-
actinin or in spectrin determining the protein structure (Noegel et al., 1987; Djinovic-
Carugo et al., 2002). 
To understand whether N-terminal sequences of Nesprin-1 can interact with 
themselves, bacterially produced GST-fusion proteins encompassing several spectrin 
repeats of Nesprin-1-165 (aa 573-858, 859-1144 and 1145-1431; Figure 8A) was 
used to pull down the corresponding GFP-tagged proteins from COS7 cells.  
While all fusion proteins pulled down their GFP-tagged counterpart, GST alone did 
not interact with anyone of the GFP fusion proteins (Figure 8B). Furthermore, 
Nesprin-1-165-GFP was transfected in COS7 cells and the GST-fusion proteins used 
in pull down experiments. Interestingly, Nesprin-1-165-GFP was precipitated with 
GST-573-858 and GST-1145-1431, but not with GST-859-1144. The polypeptide 
encompassing aa 859-1144 encodes part of SR6, SR7, 8 and part of 9 which in the 
comparison showed a lower resemblance to the ones of α-actinin. GST alone also 
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did not bind to Nesprin-1-165-GFP (Figure 8C, D). Our results imply that Nesprin-1 
oligomerizes through N-terminal spectrin repeats. 
 
 
Figure 8: N-terminal spectrin repeats of Nesprin-1 can self-associate through 
its amino terminal sequences. (A) Overview of Nesprin-1-165 and constructs used 
as GST and GFP fusion proteins. Numbers indicate the location of amino acids. (B, 
C) GFP-tagged ABD (aa 1–286), and spectrin repeats of Nesprin-1-165 (aa 573–858, 
859–1144, and 1145–1431) and full-length Nesprin-1-165 (C) were expressed in 
COS-7 cells. (B) The cell lysates were incubated with either immobilized GST-fused 
aa 1–286, 573–858, 859–1144, and 1145–1431 or GST alone for control. The 
precipitated proteins resolved in 10% acrylamide gels by SDS-PAGE. The 
membranes were probed with GFP antibody mAb K3-184-2. (C) Interaction of N-
terminal spectrin repeats with GFP Nesprin-1-165. (D) The GST-fusion proteins used 
for the pull down are shown by Coomassie Blue staining (bottom panel). 
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2.1.2 The C-terminus of Nesprin-1 interacts with Nesprin-2 
By immunoprecipitation experiments we next asked whether the possibility of an 
association between Nesprin-1 and Nesprin-2 exists. Human fibroblasts (HF) were 
transfected with plasmids encoding GFP-tagged Nesprin-1 polypeptides that were 
differently composed and possessed or lacked the KASH domain (aa 8034-8749; 
7938-8644) (Figure 9A, B).  
 
 
Figure 9: Nesprin-1 interacts with Nesprin-2. (A) GFP-tagged Nesprin-1 (aa 8034-
8749; 7938-8644) were expressed in HF cells. Numbers indicate the location of 
amino acids and used for immunoprecipitation experiments. Immunoprecipitation was 
carried out with GFP-TRAP beads. Detection of precipitated proteins was with mAb 
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K3-184-2. The blot was further probed with pAbK1 and SpecII antibodies specific for 
Nesprin-2 and Nesprin-1, respectively. (B) Schematic of the Nesprin-1 constructs. (C) 
HF cells were transfected with plasmids allowing GFP-Nesprin-1-8034-8379, and 
GFP-Nesprin-1-7938-8644 expression (green) and stained with Lamin B1 (red), and 
DAPI (blue). Scale bar, 10 μm. 
 
GFP transfected cells served as negative control for Nesprin-1 and Nesprin-2 
interaction. The proteins were immunoprecipitated using GFP-TRAP beads and the 
resulting blot probed with pAbK1 specific for Nesprin-2 and SpecII specific for 
Nesprin-1. 
We found that Nesprin-2 proteins detected by pAbK1 which is directed against C-
terminal Nesprin-2 sequences precipitated with GFP-Nesprin-1-8034-8749, but not 
with GFP-Nesprin-1-7938-8644. The interacting domain is therefore located within 
the C-terminal sequences of Nesprin-1. GFP alone did not bind to Nesprin-2 (Figure 
9A). Furthermore, we studied the subcellular localization of GFP-Nesprin-1-8034-
8749 and GFP-Nesprin-1-7938-8644. GFP-Nesprin-1-8034-8749 localized mostly to 
the NE as revealed by Lamin B1 colocalization. GFP-Nesprin-1-7938-8644, which 
lacks the KASH domain containing the transmembrane region, was also present at 
the NE but was most prominent in the cytoplasm (Figure 9C).  
 
2.1.3 Nesprin-3 is able to recruit vimentin to the nucleus 
Our group had previously reported that N-terminal sequences of Nesprin-1 can 
associate with N-terminal spectrin repeats of Nesprin-3 (Taranum et al., 2012a). 
Nesprin-3 binds to plectin, a huge protein which associates with intermediate 
filaments. 
Earlier reports indicate that Nesprin-1 and -2 through their association with F-actin 
can assemble an F-actin cage around the nucleus (Khatau et al., 2009). In analogy 
we asked whether Nesprin-3 is able to recruit an intermediate filament network to the 
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nucleus. Since Nesprin-3 is not normally expressed in COS7 cells (Wilhelmsen et al., 
2005), HA-Nesprin-3 was expressed in these cells to study vimentin localization. In 
untransfected cells, vimentin staining was not particularly enriched around the 
nucleus. However, vimentin colocalized with Nesprin-3 in HA-Nesprin-3 expressing 
cells (Figure 10) extending recent report findings from zebrafish to mammalian cells 
(Postel et al., 2011).  By contrast, GFP-tagged Nesprin-1 ABD was recruited to the 
nuclear envelope but it did not affect vimentin localization (Figure 10).  
 
 
Figure 10: Nesprin-3 recruits intermediate filaments to the nuclear envelope in 
COS7 cells. COS7 cells stained for vimentin reveal the typical cytoskeletal staining. 
In HA-Nesprin-3 transfected COS7 cells vimentin was recruited to the NE and co-
localized with HA-Nesprin-3. GFP-fused ABD-Nesprin-1 was recruited to the nuclear 
envelope but it did not affect vimentin localization. Confocal images are shown in 
(Taranum et al., 2012a). Size bars, 10 μm. 
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2.2 Nesprin-1 role in tumorigenesis 
2.2.1 Nesprin-1 isoform expression in cancer cell lines 
As mutations in SYNE1 have been identified in different types of human cancers and 
Nesprin-1 transcripts were down regulated at early tumor stages in a wide range of 
human carcinomas ((Marme et al., 2008); www.oncomine.org), we probed several 
human and murine cancer cell lines with Nesprin-1 specific antibodies by 
immunoblotting and immunofluorescence analysis. Monoclonal antibody K43-322-2 
generated against spectrin repeats 9, 10 and 11 (Figure 11A) recognized proteins of 
~600, 400, 300, 250, 150, 55 and 50 kDa in CH310T1/2 cells. The proteins 
correspond in their molecular weights to Nesprin-1 isoforms described in a recent 
detailed analysis (Rajgor et al., 2012). 
The ~600 and 400 kDa proteins were absent from all cancer cell lines and only the 
~150 kDa protein was present with the exception of WIDR, where ~300, 250, 150 
and 60 kDa proteins were detected. In the CT26 and Huh7 cell lysates the signal was 
rather faint, even after prolonged exposure (Figure 11B). Furthermore, a protein of 
high molecular weight which presumably corresponds to Nesprin-1 Giant (Taranum 
et al., 2012a) was detected in C2F3, HaCaT, and HeLa and Hep3B cell lysates. 
Based on the low expression levels of the N terminal Nesprin-1 isoforms in Hep3B 
and Huh7 liver cancer cells compared to colon, cervic, and skin cancer cells, we 
focused our studies on these cell lines. Furthermore, recent data also suggested that 
Nesprin-1 expression levels are significantly reduced in liver cancer samples 
compared with matched normal tissue (www.oncomine.org). 
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Figure 11: Nesprin-1 isoforms in various cell lines. (A) Location of the binding 
sites of Nesprin-1 antibodies. The largest isoform Nesprin-1 giant is depicted. ABD, 
actin binding domain. (B) Lysates were separated on a 3-15% SDS-PA gradient gel 
and probed with mAb K43-322-2 to detect N terminal isoforms. Arrow heads point to 
proteins discussed in the main text. Tubulin amounts were checked on a separate 
gel. 
 
Nesprin-1 C-terminal isoforms were identified in Hep3B and Huh7 cell lysates with 
polyclonal SpecII antibodies directed against the C-terminus of Nesprin-1(Taranum et 
al., 2012b). In fibroblasts we detected a 400 kDa protein which was absent from 
Hep3B and Huh7. Instead, they harbored low levels of 100 kDa and in case of 
Hep3B of 250 kDa proteins (Figure 12A). When probing for Nesprin-2, we detected 
several isoforms of Nesprin-2 with polyclonal antibodies pAbK1 directed against the 
C-terminus of Nesprin-2. The amounts were significantly higher in Hep3B and Huh7 
cells as compared to fibroblasts (Figure 12B).  
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Figure 12: Cancer cells have alterations in nuclear envelope components. (A) 
Nesprin-1 expression in human fibroblasts (HF), Hep3B and Huh7 cells using SpecII 
antibodies. The blots were probed with Emerin, Lamin A/C, Lamin B1, LAP2, SUN1 
and SUN2 antibodies. Tubulin was used to assess equal loading. (B) Presence of 
Nesprin-2 as detected with pAbK1 directed against the C-terminus. NPC proteins 
were detected with mAb414. (C) Changes at the protein level in HF, Hep3B and 
Huh7 cell lines as determined by western blotting. Fold change of Emerin, Lamin 
A/C, Lamin B1, LAP2, SUN1, SUN2 in HF, Hep3B and Huh7 cells. Band intensities 
were normalized relative to the loading control (tubulin). Histogram representing fold 
changes in band intensity. The results are the average from 3 independent 
experiments (*p<0.05, **p<0.001). 
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In further studies we compared Nesprin-1 expression in lysates from normal 
mammary tissue (N1, N2, N3) and tumor tissue (T1, T2, T3) of different patients. The 
SpecII antibodies recognized primarily a ~55 kDa protein which was strongly reduced 
in the tumor tissue (Figure 13A, B). 
 
 
Figure 13: Nesprin-1 is reduced in human tumor tissues. (A) Nesprin-1 
expression in normal (N1, N2, N3) and tumor (T1, T2, T3) mammary tissues using 
SpecII for detection. Upper panel, PonceauS staining of the nitrocellulose membrane. 
(B) Histogram representing fold change in band intensity of Nesprin-1 for normal and 
tumor tissues (*p<0.05). 
 
2.2.2 Hep3B and Huh7 have nuclear shape defects and alterations in 
components of the nuclear envelope  
The nuclei of Hep3B and Huh7 cells were enlarged and often displayed a deformed 
morphology in contrast to the oval shape in HFs which we used for control. We 
further noted folds, lobulations, protrusions, blebs and micronuclei (Figure 14A, B).  
In Hep3B, 37% of the cells had misshapen nuclei, in Huh7 26% and in control 7%. 
Micronuclei were observed in 11% of the Hep3B cells, in 8% in case of Huh7 and 1% 
of HF cells (Figure 14B). SpecII antibodies labeled the NE in fibroblasts and gave 
some cytoplasmic staining in the vicinity of the nucleus whereas the Nesprin-1 
presence at the NE was strongly reduced in the cancer cells (Figure 14A). 
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Figure 14: Hep3B and Huh7 have nuclear shape defects and alterations in 
components of the LINC complex. (A) Staining was with SpecII (green) to detect 
Nesprin-1 and a mAb specific for Emerin (red). DAPI staining of DNA is in blue. 
Arrow heads indicate nuclei with regular shape and staining for SpecII and Emerin. 
Scale bar, 10 µm. (B) Huh7 cells have nuclear shape defects and alterations in 
components of the nuclear envelope. Staining was with polyclonal SpecII antibodies 
against Nesprin-1 (green), Lamin B1 (green), SUN1 (green) and mAb Emerin (red) 
antibodies. DAPI staining of DNA is in blue. Scale bar, 10 μm. Upper panel, statistical 
analysis of nuclear aberrations. 300 nuclei each for HF (passage 7), Hep3B and 
Huh7 were evaluated (**p<0.001). 
 
Remarkably, Emerin was nearly absent from the NE in the cancer cells (Figure 14A, 
B). The absence of Emerin was also confirmed in western blots (Figure 12A, C). 
Lamin A/C specific antibodies showed a rim like staining pattern in HFs. In Hep3B 
and Huh7 cells a discontinuous, patchy Lamin A/C distribution at the NE was 
observed. Lamin B1 staining of the NE was homogenous in HFs, in Hep3B and Huh7 
cells the distribution was patchy (Figure 15A).  
LAP2, a member of a group of NE proteins involved in tethering chromatin to the 
nuclear envelope and affecting gene expression, showed an unaltered localization at 
the NE in Hep3B and Huh7 cells. The expression level appeared to be significantly 
higher than in fibroblasts which expressed low amounts of LAP2 (Figure 15A).  
NPC proteins regulate nuclear transport, are connected to chromatin and participate 
in the regulation of transcription. Increased expression of individual NPC components 
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has been noticed in several tumor types. Hep3B and Huh7 cells exhibited NE 
staining with mAb 414, which recognizes several NPC proteins based on the 
presence of FXFG-repeats, however staining was reduced in nearly 45% of the cells 
(Figure 15B, C). 
 
 
Figure 15: Nuclear envelope components are altered in Hep3B and Huh7 cells. 
(A) Distribution of Lamin A/C, Lamin B1, and LAP2 in HF, Hep3B and Huh7 cells. 
Arrow heads indicate the observed defects. Scale bar, 10 μm. (B) HF, Hep3B and 
Huh7 cells were stained with anti-Nesprin-1 SpecII (green), mAb NPC (red), DAPI 
(blue). Arrow heads point to normal shaped nuclei stained with SpecII and NPC. 
Scale bar, 10 μm. (C) Statistical analysis of NPC staining. 200 cells per strain were 
analysed (*p<0.0001).  
 
Analysing individual proteins by western blotting, we found that NUP153 levels were 
higher in Hep3B and Huh7 cells compared to the HF control and NUP116 levels were 
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decreased (Figure 12B). In colon cancer cell lines, localization of Nesprin-1 and other 
nuclear envelope components was unperturbed (Figure 16). 
 
 
Figure 16: Nuclear envelope components in colon cancer cells. Distribution of 
Nesprin-1 detected by anti-ABD-Nesprin-1, Emerin, NPC, Lamin A/C, Lamin B1, 
Nesprin-2 as detected by pAbK1 in CT26, CMT93, WIDR, C2F3 cells. DAPI staining 
of DNA is in blue. Scale bar, 10 μm. 
 
Immunofluorescence analysis for SUN proteins revealed a rim like staining for SUN1 
in Hep3B and Huh7 cells. Some cells exhibited a brighter SUN1 staining which was 
associated with misshapen and enlarged nuclei (Figure 17, arrows). When we 
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examined the amounts of SUN1 and SUN2 in western blots, we found that 
particularly the SUN1 levels were higher in Hep3B and Huh7 as compared to HFs 
(Figure 12A, C). Quantification of the mRNA levels by qRT-PCR showed that SUN1 
and SUN2 mRNA were significantly increased in Hep3B and slightly increased in 
Huh7 cells (Figure 17B).  
 
 
Figure 17: Cells with misshapen and enlarged nuclei exhibited a brighter SUN1 
staining. (A) SUN1 (red) staining in Hep3B and Huh7 cells, DAPI, blue. Arrow heads 
point to cells with high SUN1 expression and misshapen and enlarged nuclei. Scale 
bar, 10 μm. (B) SUN1 and SUN2 transcript levels in control, Hep3B and Huh7 cells 
as determined by qRT-PCR. Significant up-regulation of SUN1 and SUN2 was 
detected in Hep3B, Huh7, and KD-HF cells compared to HF cells (*p<0.05, 
**p<0.001). The SUN1 and SUN2 mRNA level in HF at passage 7 was taken for 
reference. For normalization, GAPDH was used. 
 
2.2.3 The centrosome-nucleus distance is increased in Hep3B and Huh7 
cells 
Centrosomal aberrations are frequently observed in cancer cells. Normal cells in the 
G1 phase of the cell cycle have a single centrosome which is attached to the 
nucleus. In HFs, centrosomes were positioned near the nucleus at a mean distance 
of 0.33±0.25 μm. In Hep3B and Huh7 cells the distance between the centrosome and 
the nucleus was highly variable and cells with normal shaped as well as deformed 
nuclei displayed an increased centrosome-nucleus distance. In Hep3B and Huh7 
Results 
 35 
cells we observed an increase to 6.29±4.24 μm and 3.56±3.0 μm, respectively 
(Figure 18A, B). The number of centrosomes also differed. 15% of Hep3B and 14.3% 
of Huh7 cells had more than two centrosomes (Figure 18C). The centrosome number 
was not necessarily associated with nuclear shape changes.  
 
 
Figure 18: Centrosome-nucleus-distance is altered in Hep3B and Huh7 cells. 
(A) Centrosome-nucleus-distance is altered in Hep3B and Huh7 cells. γ-Tubulin (red) 
specific antibodies were used to label the centrosome. DAPI (blue), nuclear staining. 
Scale bar, 10 μm. (B) Statistical evaluation of the centrosome-nucleus distance. (C) 
Statistical evaluation of cells with >2 centrosomes. Error bars indicate standard 
deviations (*p<0.001, **p<0.0001). 
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2.3 Loss of Nesprin-1 
2.3.1 Knock down of Nesprin-1 elicits changes that are observed in 
cancer cell lines  
To test whether a loss of Nesprin-1 can cause the changes observed in the cancer 
cells, we reduced the amounts of Nesprin-1 by shRNA mediated knock down in 
C3H10T1/2 (KD-CH310T1/2) and in human fibroblasts (KD-HF) using knock down 
vectors targeting N-terminal and C-terminal sequences of human or mouse Nesprin-1 
(see Materials and Methods) and analyzed the consequences.  
For control we used untransfected cells (HF, CH310T1/2) and cells transfected with 
the empty pSHAG-1 vector used for cloning (C-HF, C-CH310T1/2). Western blot 
analysis with mAb K43-322-2 and SpecII labeling confirmed the knock down (KD) 
(Figure 19A, B). Labeling with mAb K43-322-2 showed that in Nesprin-1 KD cells 
particularly the 250 kDa and larger proteins of 400 and 600 kDa were significantly 
reduced in amounts (Figure 19A, arrow heads). The 130 kDa protein and smaller 
proteins were also less prominent. The expression level of the smallest ones were 
not altered (Figure 19A).  
Reduction of Nesprin-1 was associated with a down regulation of Emerin, Lamin B1, 
NPC proteins and LAP2. By contrast, SUN1 and SUN2 protein amounts were 
increased (Figure 19A, C). This was also observed for SUN1 in CH310T1/2 in which 
the levels of endogenous SUN1 were quite low (Figure 19A). An increase was also 
seen at the transcript level as revealed by qRT PCR (Figure 17B). 
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Figure 19: Loss of Nesprin-1 elicits changes that are observed in cancer cell 
lines. (A) Immunoblot analysis of Nesprin-1 Giant knock down HF and CH310T1/2 
cells. Detection was with mAb K43-322-2 and pAb SpecII. Tubulin served as control. 
Emerin, Lamin A/C, Lamin B1, LAP2, SUN1 and SUN2 specific antibodies were used 
for analysis. Human and murine Emerin differ in their primary sequence explaining 
the observed difference in molecular weight. (B) The blot in (A) was reprobed with 
SpecII antibodies and mAb414 to detect NPC proteins. (C) Changes of NE 
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components at the protein level after knock down of Nesprin-1. Knock down was 
carried out using plasmids targeting the N and C terminal regions of Nesprin-1. 
Histogram representing fold changes in band intensities of Emerin, Lamin B1, LAP2, 
SUN1 for HF, C-HF, KD-HF, CH310T1/2, C-CH310T1/2, KD-CH310T1/2 cells 
(*p<0.05). 
 
For Nesprin-1, alterations in transcript levels were assessed by qRT-PCR. KD-HF 
and Huh7 cells showed significant reductions (Figure 20). 
 
 
Figure 20: The transcript levels of Nesprin-1 vary significantly in Hep3B, Huh7, 
HF, C-HF, and KD-HF cells as determined by qRT-PCR. Significant down-
regulation of Nesprin-1 was detected in Hep3B, Huh7, and KD-HF cells compared to 
HF cells (*p<0.05, **p<0.0001). The primers used for amplification were located in 
the N terminus of Nesprin-1. For normalization GAPDH was used. 
 
In immunofluorescence analysis the clear NE staining by SpecII and Emerin 
antibodies was lost and some residual punctate staining in the cytosol of KD-HF and 
KD-CH310T1/2 cells was seen (Figure 21A). The NPC antibodies labeled the nuclear 
envelope in control fibroblasts and in CH310T1/2, whereas in the knock down cells 
NPC staining is strongly reduced (Figure 21B).  
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Figure 21: Effect of Nesprin-1 knock down on NE components. (A, B) Cells were 
stained for Nesprin-1 with pAb SpecII (green), Emerin (red), mAb NPC (red) and 
DAPI (blue). Knock down was carried out with vectors targeting N and C terminal 
sequences of Nesprin-1. Arrow heads indicate the NE phenotypes described. Scale 
bars, 10 μm. 
 
Nearly all cells that had an altered staining pattern exhibited nuclear shape defects. 
SUN1 antibodies strongly stained the NE in KD-HF. Cells with particularly strong 
SUN1 staining exhibited a variety of nuclear shape defects including folds, 
lobulations, blebs and micronuclei (Figure 22).  
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Figure 22: SUN1 staining revealed a variety of nuclear shape defects including 
folds, lobulations, blebs and micronuclei. SUN1 (red) staining in Hep3B, Huh7, C-
HF, KD-HF, C-CH310T1/2, KD-CH310T1/2 cells. Nesprin-1 was detected with mAb 
K58-398-2 (green). Nuclei are stained by DAPI (blue). Scale bars, 10 μm. 
 
Heat treatment is often used to probe the stability of the nuclear envelope (Vigouroux 
et al., 2001). To understand the link between Nesprin-1 loss and heat resistance, the 
cells were stained with LAP2 to evaluate nuclear shape changes after heat shock. 
When we incubated cells for 30 min at 45°C, Nesprin-1 knock down fibroblasts, 
Hep3B and Huh7 cells exhibited increased nuclear deformations with folds and 
pleats after heat treatment (Figure 23A, B). Many nuclei also displayed notches, tears 
and herniations (Figure 23A, arrow heads). Knock down with plasmids targeting N-
terminal or C-terminal sequences showed similar results as knock down experiments 
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where we used vectors targeting N-terminal and C-terminal sequences together (data 
not shown).  
 
 
Figure 23: Loss of Nesprin-1 leads to hypersensitivity towards heat shock. (A) 
Cells were immunostained with SpecII (green) and LAP2 (red) antibodies to detect 
the nuclei deformations after heat shock at 45°C for 30 min. Arrow heads point to 
nuclear deformations. Scale bar, 10 µm. (B) Histograms representing the percentage 
of deformed nuclei of cells before (white bars) or after heat shock (black bars). Data 
are the mean ±SD from three samples per group of three independent experiments. 
Statistically significant differences were determined between before and after heat 
shock groups (*p<0.05, **p<0.0001). 
 
When we quantified the defects for each cell type, we found that Hep3B and Huh7 
had more abnormal nuclei in general. This number increased only slightly upon heat 
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treatment. Compared with unheated Hep3B (42%) and Huh7 (34%) cells, deformed 
nuclei after heat shock was 46% for Hep3B and 41% for Huh7 cells. Stronger 
increases in the number of deformed nuclei were observed for the KD-HF cells 
(35%±4.09 before and 41%±3.22 after heat shock). Moreover, no significant changes 
were observed among C-CH310T1/2 cells before (7% misshapen nuclei) or after 
(10%) heat shock. The extent of nuclear deformations caused in KD-CH310T1/2 
(29.5%±4.37 before and 40.83%±2.86 after heat shock) was similar to heat shock 
experiments performed in KD-HF cells (Figure 23B). These results suggest that heat 
treatment leads to more deformed nuclei in Nesprin-1 KD, Hep3B and Huh7 cells. 
 
2.3.2 The centrosome-nucleus distance is increased in Nesprin-1 KD 
cells 
The LINC complex proteins play essential roles in centrosome biology (Salpingidou 
et al., 2007; Schneider et al., 2008; Zhang et al., 2009). Moreover, recent studies 
revealed that centrosome defects, including alterations in centrosome shape, size, 
number, position, composition lead to tumorigenesis (Lingle and Salisbury, 2001; 
Fukasawa, 2005; Salisbury, 2005; Nigg, 2006; Hassold et al., 2007). To further 
address whether the Nesprin-1 is associated with centrosome position and number, 
the cells were stained with Ɣ-tubulin. We investigated the centrosome-nucleus 
distance and centrosome number upon loss of Nesprin-1 and found that centrosomes 
were positioned 0.35±0.29 and 3.20±2.34 μm away from the NE in C-HF and 
Nesprin-1 KD-HF cells, respectively. Similarly, in Nesprin-1 KD-CH310T1/2 cells the 
mean centrosome-nucleus distance increased from 0.44±0.27 μm in C-CH310T1/2 
cells to 2.40±1.49 μm in Nesprin-1 KD-CH310T1/2 cells (Figure 24A, B).  
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Figure 24: The centrosome-nucleus distance and centrosome number are 
increased in Nesprin-1 KD cells. (A) Centrosome position in C-HF, KD-HF, C-
10T1/2, and KD-10T1/2 cells. Centrosomes were visualized with a -tubulin antibody 
(red), Nesprin-1 with SpecII (green). The nucleus was stained with DAPI (blue). Scale 
bars, 10 μm. (B) Statistical evaluation of the centrosome-nucleus distance. 100 cells 
for each cell line were evaluated (*p<0.0001). (C) Statistical analysis of the 
percentage of cells with >2 centrosomes was calculated from three independent 
experiments (100 cells were counted per experiment, *p<0.05, **p<0.0001). 
 
Nesprin-1 loss was also accompanied by alterations of the centrosome number. More 
than two centrosomes were seen in 3.3% C-HF, for Nesprin-1 KD-HF this number 
increased to 10% and for CH310T1/2 it increased from 6% in the C-CH310T1/2 to 
11% after knock down (Figure 24C). 
 
Results 
 44 
2.3.3 Loss of Nesprin-1 leads to cytoskeletal alterations  
To gain insight into the role of Nesprin-1 in cytoskeleton organization, cells were 
stained with TRITC-phalloidin to visualize the actin cytoskeleton and mAb YL1/2 to 
stain the microtubule network. In C-HF and C-CH310T1/2 cells F-actin was abundant 
and distributed throughout the cells. Nesprin-1 KD fibroblast, Hep3B, and Huh7 cells 
had fewer stress fibers and displayed irregular F-actin staining in particular over and 
around the nucleus where filaments were nearly absent (Figure 25A). Hep3B and 
Huh7 cells had fewer microtubules and the network appeared disorganized. The 
microtubule organization was also altered in KD-HF and KD-CH310T1/2 cells and a 
circular arrangement of microtubules in the cell periphery was noted (Figure 25B).  
Cell migration requires precisely orchestrated changes in the actin and tubulin 
organization. In particular, migration of tumor cells has been extensively studied due 
to its importance in the process of cancer metastasis (Yamaguchi et al., 2006; Sahai 
et al., 2007). As loss of Nesprin-1 led to distinct changes in the F-actin and 
microtubule system, we analyzed the migration behavior of Nesprin-1 KD fibroblast, 
Hep3B and Huh7 cells after scratch wounding. C-KD exhibited a mean speed of 
migration of 11±1.2 (C-HF) and 13.1±1.8 (C-CH310T1/2) μm/hour whereas Nesprin-1 
KD cells migrated with a cell velocity of 15.6±1.09 (KD-HF) and 20.8±1.0 (KD-
CH310T1/2) μm/hour. In Hep3B and Huh7 cells, cell migration speed was markedly 
enhanced and the cell velocities were measured as 19.2±0.80 and 16.1±2.6 μm/hour, 
respectively (Figure 25C). 
These findings could indicate that Nesprin-1 has an inhibitory role for the 
reorganization of the actin and microtubule cytoskeleton and for cell migration and its 
loss leads to enhanced migration as it is required for tumor metastasis and invasion.  
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Figure 25: Alterations in the cytoskeletal networks upon loss of Nesprin-1. (A) 
Detection of the actin cytoskeleton in Hep3B, Huh7, Nesprin-1 KD-HF and KD- 
CH310T1/2 cells. Cells were fixed with PFA and stained for Nesprin-1 with pAb 
SpecII (green), F-actin with TRITC-Phalloidin (red), and DAPI (blue). Scale bar, 10 
μm. (B) Detection of the microtubule network in Hep3B, Huh7, Nesprin-1 KD-HF, KD- 
CH310T1/2 cells. Arrow heads indicate cells with a disorganized microtubule 
network. Cells were stained with YL1/2 for tubulin (red), pAb SpecII (green) and DAPI 
(blue). Scale bars, 10 μm. (C) Histogram representing the cell velocity (μm/h). The 
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cell velocity was calculated using Image J. The values represent the mean ± SD of 
three separate experiments. Student’s t-test was used for the evaluation (*p<0.001, 
**p<0.0001).  
 
2.3.4 Senescence is increased in Nesprin-1 knock down fibroblasts 
Cellular aging or senescence is formally described by Hayflick as a limited 
proliferation of cells during in vitro propagation (Hayflick, 1965). In vivo senescent 
cells stimulate biological processes that are associated with aging and tumorigenesis 
(Rodier and Campisi, 2011). A recent study indicated that cancer cells can undergo 
senescence due to several mechanisms such as telomere shortening, DNA-damage 
and oxidative stress (Di Micco et al., 2006). Furthermore, cells harboring defects in 
components of the NE are reported to display an increased senescence (Le Dour et 
al., 2011; Taranum et al., 2012b). 
To investigate whether Nesprin-1 loss leads to cellular aging, cells were plated and 
used for an assay in which the number of β-galactosidase positive cells (senescence-
associated β-galactosidase, SA-β-gal) was determined. Notably, HF (6%) and 
CH310T1/2 (4.6%) cells displayed low percentage of blue staining. The extent of 
cellular senescence was similar between C-HF and C-CH310T1/2 cells (9%); in 
Hep3B and Huh7 cells, high levels of senescence were observed (51% and 92%, 
respectively). In KD-HF cells more than 80% were β-galactosidase positive. 9% of 
the C-CH310T1/2 cells were positive and after Nesprin-1 KD this number increased 
to 40% (Figure 26).  
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Figure 26: Loss of Nesprin-1 leads to cellular senescence and alterations in the 
cytoskeleton. (A) Staining for senescence associated β-galactosidase. Cells were 
imaged using bright field microscopy at 40x magnification. (B) Quantification of SA-β-
gal-positive cells. Standard deviations are from three independent experiments 
counting 100 to 500 cells in each experiment (*p<0.001, **p<0.0001).  
 
2.4 Nesprin-1 and DNA damage response (DDR) network  
2.4.1 ABD of Nesprin-1 interact with DNA mismatch repair proteins MSH2 
and MSH6 
In a search for Nesprin-1 interaction partners we performed pull-down experiments 
with GST-Nesprin-1-286 and C2F3 cell lysates. Among the identified proteins, the 
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DNA mismatch repair protein (MSH2) and DNA damage binding protein-1 (DDB1) 
were chosen for further experiments (Table 4).  
 
Table 4. The possible interaction partners of Nesprin-1. Pull-down assay was 
performed using GST-Nesprin-1-286 and C2F3 cell lysates. 
 
Protein Sequence 
coverage 
(%) 
Score MW 
(kDa) 
No. of 
unique 
Peptides 
Plectin  32.6 6056.1 533.9 138,00 
Filamin-C  6.0 644.3 290.9 12,00 
60S ribosomal protein L7  11.5 176.8 31.4 3,00 
Filamin-A  2.3 158.7 281.0 4,00 
Cytoplasmic dynein 1 heavy chain 1  1.0 146.1 531.7 4,00 
Histone H1.4  5.5 50.4 22.0 1,00 
60S ribosomal protein L6  3.0 48.5 33.5 1,00 
Keratin, type II cytoskeletal 1  1.9 37.9 65.6 1,00 
Myosin-9  39.6 3835.4 226.2 82,00 
Myosin-Va  4.3 211.5 215.5 6,00 
Ribosome-binding protein 1  3.2 113.6 172.8 3,00 
Nischarin  0.8 54.8 174.9 1,00 
Cytoskeleton-associated protein 5  0.6 48.6 225.5 1,00 
Zinc transporter 1  2.8 37.8 54.7 1,00 
Importin-7  9.0 363.2 119.4 7,00 
Caprin-1  5.9 245.0 78.1 4,00 
DNA damage-binding protein 1  8.7 221.7 126.8 7,00 
Aspartyl/asparaginyl beta-hydroxylase  7.2 133.1 83.0 4 
Probable ATP-dependent RNA helicase  1.4 49.4 113.8 1 
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Importin-9  1.1 48.0 116.0 1 
Zinc transporter 1  2.8 44.8 54.7 1 
Dynein heavy chain 17, axonemal  0.2 41.4 511.3 1 
Nucleolin 39.9 1397.1 76.7 35,00 
AP-2 complex subunit alpha-2  14.3 408.2 104.0 11,00 
AP-2 complex subunit beta-1  11.2 363.3 104.5 10,00 
Coatomer subunit beta 8.2 238.4 107.0 6,00 
AP-2 complex subunit alpha-1  7.1 233.9 107.6 6,00 
Transcription intermediary factor 1-beta  11.9 199.8 199.8 5,00 
Endoplasmin  6.6 195.2 92.4 4,00 
DNA mismatch repair protein Msh2  4.4 136.5 104.1 3,00 
DNA replication licensing factor MCM3  3.4 90.4 91.5 2,00 
Rho guanine nucleotide exchange factor 
2  
1.9 63.6 111.9 1,00 
Kinesin-like protein KIF2A  1.6 57.5 79.7 1,00 
Alpha-actinin-1  1.3 48.1 103.0 1,00 
Apoptosis-inducing factor 1, 
mitochondrial  
5,20 127.7 66.7 3,00 
ATP-dependent RNA helicase DDX3X  5,60 113.0 73.1 3,00 
Eukaryotic translation initiation factor 3 
subunit D  
4,70 99.5 63.9 2,00 
ADP-ribosylation factor GTPase-
activating protein 3  
3,30 73.8 57.4 1,00 
RNA-binding protein 39  2,80 38.2 59.5 1,00 
DNA polymerase delta subunit 3  3.0 34.4 50.8 1,00 
Hypermethylated in cancer 2 protein  1,50 44.5 72.6 1,00 
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To verify the interaction we repeated the experiment with HeLa cell lysates and 
probed the precipitate directly for the presence of MSH2 with antibodies. In addition 
to MSH2 we also found MSH6 and DDB1 in the precipitate (Figure 27A). MSH2 
forms a complex with MSH6 which binds to DNA mismatches and functions in the 
repair of DNA double strand breaks (Warren et al., 2007). GST alone as control did 
not precipitate MSH2, MSH6, and DDB1. To pursue the interaction of Nesprin-1 with 
MSH2, MSH6 and DDB1 in vivo, we transiently expressed GFP-Nesprin-1-286 in 
COS7 cells. GFP-Nesprin-1-286 colocalized with MSH2 and MSH6 at the nuclear 
envelope and also inside the nucleus (Figure 27B). 
 
 
Figure 27: Nesprin-1 interacts with DNA repair proteins. (A) Interaction of 
Nesprin-1 with MSH2, MSH6, and DDB1. HeLa cells were incubated with GST-
Nesprin-1-286 and GST for control. Detection of the 105 kDa MSH2, 163 kDa MSH6 
and 127 kDa DDB1 in the pull down was with MSH2, MSH6, and DDB1 specific 
antibodies, respectively (lower panels). Upper panel, Coomassie Blue staining of the 
gel. (B) COS-7 cells were transfected with GFP-Nesprin-1-286 (green) and stained 
for MSH2 (red) and MSH6 (red), DAPI (blue). Scale bar, 10 μm. 
 
We then carried out immunoprecipitation experiments and included also UV-treated 
cells. GFP-Nesprin-1-286 was immunoprecipitated from nuclear extracts using GFP 
beads and the precipitates probed for the presence of MSH2, MSH6, and DDB1. We 
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found that MSH2, MSH6, and DDB1 coprecipitated with GFP-Nesprin-1-286 from 
untreated and UV-treated nuclear extracts showing the relevance of the interaction 
also in the situation of DNA damage (Figure 28).  
 
 
Figure 28: Nesprin-1 interacts with DNA repair proteins in vivo. HF cells were 
transfected with plasmids coding for GFP-ABD-Nesprin-1 and GFP and nuclei 
isolated and used for immunoprecipitations using GFP specific antibodies. MSH2, 
MSH6 and DDB1 coimmunoprecipitate with Nesprin-1 from nuclear extracts. MSH2; 
MSH6 and DDB1 also coimmunoprecipitated from nuclear extract upon UV-C 
treatment (20 J/m2). GFP-ABD-Nesprin-1 and GFP were detected with mAb K3-184-
2 (upper panel). Subcellular fractionation was confirmed by probing with Lamin B1 
antibodies.  
 
Next we tested whether MSH2 and MSH6 levels were affected by Nesprin-1 levels. In 
immunoblot analysis we found that Huh7 and KD-HF cells expressed lower levels of 
MHS2 and nearly no MSH6 was detected whereas their levels were considerably 
higher in Hep3B and C-HF cells (Figure 29A, B). The amounts of Nesprin-1 detected 
with anti-ABD-Nesprin-1 were reduced compared to C-HF cells as were the transcript 
levels (Figure 20). We also included the human colorectal cell line DLD-1 which is 
deficient in DNA mismatch repair (MMR) in order to test whether MMR deficiency is 
correlated with the Nesprin-1 levels. In western blots we found low levels of MSH2 
and nearly no MSH6 and with Nesprin-1-ABD antibodies we detected strongly 
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reduced amounts of the ~100 kDa and 250 kDa proteins that were also present in the 
cancer cell lines (Figure 29A, B). 
 
Figure 29: Loss of Nesprin-1 affects the MMR network. (A) Immunoblot analysis 
of DLD-1, Hep3B, Huh7, HF and KD-HF cells. Detection was with anti-ABD-Nesprin-
1 and MSH2 and MHS6 antibodies. Tubulin served as control. (B) Histograms 
representing fold changes of band intensities of MSH2 and MSH6. Band intensities 
were normalized relative to the loading control (tubulin). Data are the mean ±SD from 
three samples per group of three independent experiments (*p<0.001, **p<0.0001). 
 
Furthermore, we observed reduced expression of MSH2 and fewer MSH6 foci in KD-
HF cells compared to C-HF cells (Figure 30A, B). Quantification of the MSH2 and 
MSH6 mRNA levels by qRT-PCR showed that they were significantly reduced in 
Nesprin-1 KD-HF cells. Similar results were obtained with KD-HeLa cells (Figure 
30C). 
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Figure 30: Nesprin-1 loss and MMR proteins. (A) Effect of Nesprin-1 knock down 
on MSH2 (red) and MSH6 (red). Nesprin-1 was detected with K43-322-2 (green) or 
pAb SpecII (green). Nuclei were stained with DAPI (blue). Arrow head indicates the 
KD-HF cell. Scale bars, 10 μm. (B) Quantification of the percentage of cells 
presenting >20 MSH6 foci for C-HF (red bar) or KD-HF (pink bar). Error bars 
represent standard deviations (**p<0.0001). (C) MSH2, MSH6 and Nesprin-1 
transcript levels in C-HF, KD-HF, C-HeLa, and KD-HeLa as determined by qRT-PCR. 
Significant down-regulation of MSH2 and MSH6 was detected in KD-HF and KD-
HeLa cells compared to C-HF and C-HeLa cells (*p<0.05, **p<0.0001). For 
normalization, GAPDH was used. 
 
We also studied the NE characteristics of DLD-1 cells and found abnormal nuclear 
morphology, centrosomal aberrations, altered expression of NE components as were 
observed in Nesprin-1 KD cells (Figure 31). In this context it is interesting to note that 
SYNE1 is a candidate gene for colorectal cancer, but the molecular mechanism is not 
clear (Sjoblom et al., 2006). 
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Figure 31: DLD-1 cells resemble Nesprin-1 KD cells with respect to the NE. 
Distribution of Emerin (red), NPC (red), LAP2 (red), Actin (red), SUN1 (red), Lamin 
A/C (red), Lamin B1 (red), γ-Tubulin (red), Spec2 (green), K43-322-2 (green) in DLD-
1 cells. Arrow heads indicate the observed defects. Scale bar, 10 μm. 
 
In order to determine possible effects of Nesprin-1 on the MSH2-MSH6 heterodimer 
(MutSα) during DNA replication or the repair process, C-HF and KD-HF cells were 
synchronized at G1, S or G2/M phase and the chromatin association of the proteins 
tested. The cell cycle status was confirmed by flow cytometry (FACS). MSH2 was 
present in all phases and strongly accumulated in the nucleus during S and G2/M 
phase (Figure 32A). MSH6 was primarily observed in S phase where it was present 
in the nucleus and showed some colocalization with Nesprin-1 (Figure 32B).  
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Figure 32: MSH2 and MSH6 during mitosis in Nesprin-1 KD cells. (A) KD-HF 
cells were arrested at G1, S, G2/M as indicated. Immunofluorescence was performed 
to determine nuclear distribution of K43-322-2 (green) and its colocalization with 
MSH2 (red). (B) Immunofluorescence analysis showing colocalization of MSH6 with 
Nesprin-1 in C-HF cells. Nesprin-1 (Spec II) and MSH6 localization for C-HF cells in 
G1, S or G2/M phase. The colocalization is increased in S phase. Scale bar, 10 μm. 
 
Nesprin-1 deficient HF cells had strongly reduced levels of MSH2 and MSH6 was 
undetectable (Figure 32A; data not shown). In HeLa cells the expression levels of 
MSH2 and MSH6 appeared to be higher. The results in C-HeLa and KD-HeLa cells 
resembled those for HF cells (Figure 33A, B). We conclude that localization of MSH2-
MSH6 to the nucleus and to chromatin is facilitated by Nesprin-1 leading to 
successful DNA repair. 
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Figure 33: MMR in KD-HeLa cells. (A) KD-HeLa cells were arrested at G1, S, G2/M 
as indicated. Immunofluorescence was performed to determine the distribution of 
Nesprin-1 with K43-322-2 (green) and MSH2 (red). Arrow heads point to KD-HeLa 
cells. (B) Immunofluorescence analysis showing localization of MSH6 in C-HeLa cells 
in G1, S, and G2/M phase. Nesprin-1 (Spec II, green) and MSH6 (red). Scale bar, 10 
μm. 
 
Recent work by Li and coworkers showed that H3K36me3 has a role in MMR and is 
required to recruit hMSH2-hMSH6 to chromatin (Li et al., 2013). Their results 
indicated that a maximum abundance of H3K36me3 occurred in early S phase which 
could increase the efficiency of MMR in actively replicating chromatin.  
We therefore tested for H3K36me3 presence in early S phase and found that KD-HF 
cells behaved like Nesprin-1 positive cells and showed H3K36me3 positive spots 
(Figure 34). This shows that the MSH2-MSH6 recruitment to chromatin is affected in 
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Nesprin-1 KD whereas accumulation of H3K36me3 still takes place in Nesprin-1 KD 
cells. The results imply that MSH2-MSH6 recruitment to chromatin depends not only 
on H3K36me3 but also on Nesprin-1. 
 
  
Figure 34: H3K36me3 in C-HF and KD-HF cells. K43-322-2 (green) and 
H3K36me3 (red) staining for C-HF and KD-HF cells in early S phase. Scale bar, 10 
μm. 
 
Nesprin-1 may play an important role for the function of MSH2 and MSH6 in the DNA 
mismatch repair, and a defect in this connection may also lead to alterations in earlier 
DDR events. Therefore, it is possible that the Nesprin-1 interaction with the MutSα 
complex is a constitutive cellular event required for proper DNA repair, and the 
interaction is not required for just the NE localization of MutSα complex. 
 
2.4.2 Loss of Nesprin-1 affects the DDR network 
The DDR pathway is associated with cancer development. MMR and NHEJ are two 
interlinked processes, and loss of MSH2 and MSH6 has been correlated with altered 
response to double strand breaks (DSBs) as well (Villemure et al., 2003; Shahi et al., 
2011). To gain insight into specific steps during DDR, we monitored the cellular levels 
of key components, namely histone H2AX, checkpoint kinases Chk1 and Chk2, and 
Ku70/Ku80 heterodimer in Hep3B, Huh7, C-HF and Nesprin-1 KD-HF. 
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Phosphorylation of H2AX and Chk1 and Chk2 is among the initial events that occur in 
response to DNA damage (Kastan and Lim, 2000; Liu et al., 2000; Marti et al., 2006). 
Ku70/Ku80 binds to DNA double-strand breaks during NHEJ and recruits the DNA 
repair kinase DNA-dependent protein kinase catalytic subunit to the lesion. Following 
this process, the Ku70/Ku80 heterodimer is required to inhibit nuclease binding or 
activity at broken DNA ends thereby effectively functioning to maintain genome 
stability and successful repair (Liang and Jasin, 1996; Downs and Jackson, 2004; 
Sun et al., 2012). 
In C-HF nearly no γH2AX foci marking broken DNA were observed. Upon HU 
treatment γH2AX positive spots formed (Figure 35 A).  
 
 
Figure 35: Nesprin-1 and the DDR network. (A) Nesprin-1 (pAb SpecII, green) and 
γH2AX (red) staining of Hep3B, Huh7, HF, Nesprin-1 KD-HF cells before (left) and 
after treatment (right) with hydroxyurea (HU). Loss of Nesprin-1 leads to increased 
γH2AX staining. (B) SpecII (green) and γH2AX (red) staining of Nesprin-1 KD-HF 
cells after UV treatment (arrow indicates KD-HF cells). Scale bars, 10 μm. (C) 
Quantification of the percentage of cells presenting >5 γH2AX-labelled foci before 
(white bar) or after (black bar) HU treatment. Graphs show results from at least three 
independent experiments. Error bars represent standard deviations (*p<0.001, 
**p<0.0001). 
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After knock down of Nesprin-1 a strong increase in the number of γH2AX foci was 
observed that exceeded the one of C-HF cells after HU or UV treatment and was 
indicative of an elevated DNA damage upon loss of Nesprin-1 (Figure 35B). 
Untreated Hep3B and Huh7 cells had a similar high number of γH2AX foci. This 
number was further enhanced following HU treatment both in Nesprin-1 KD-HF and 
the tumor cells (Figure 35C).  
Ku70 was present in untreated C-HF cells whereas Nesprin-1 KD-HF cells had low 
levels of Ku70. After HU treatment Ku70 levels decreased in all cell lines with the 
exception of C-HF cells where an elevated expression was noted. After HU or UV 
treatment Ku70 levels decreased in KD-HF cells (Figure 36A, B). Similar reduction of 
Ku70 expression was also observed in Hep3B and Huh7 cells after HU treatment. 
The decrease was also detected at the protein level (Figure 37A). 
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Figure 36: Loss of Nesprin-1 leads to defective recruitment of DNA repair 
proteins to DSBs. (A) Immunofluorescence analysis of Ku70 in Hep3B, Huh7, C-HF 
and KD-HF cells before and after HU treatment. pAb SpecII (green), Ku70 (red), 
DAPI (blue). Arrow heads point to Nesprin-1 KD-HF cells. Scale bars, 10 μm. (B) 
SpecII (green), Ku70 (red) staining in Nesprin-1 KD cells after UV treatment. Scale 
bar, 10 μm. 
 
Nesprin-1 reduction also had an effect on the presence of phosphorylated H2AX, 
Chk1 and Chk2 (Figure 37A-C). In all untreated cell lines no phosphorylated Chk1 
and Chk2 was detected. Upon HU treatment their levels strongly increased as 
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detected with antibodies recognizing specific phosphorylated forms in all cell lines 
except for C-HF where the increase was hardly noticeable (Figure 37D-F).  
 
 
Figure 37: Nesprin-1 is involved in DNA damage response. (A) Western blot 
analysis for determination of levels of H2AX (Ser319), CHK1 (Ser345), and CHK1 
(Ser317), CHK2 (Thr68), and Ku70 before and after HU treatment. Tubulin was used 
for loading control. (B-F) Histograms representing fold changes of band intensities of 
H2AX (Ser319), CHK1 (Ser345), and CHK1 (Ser317), CHK2 (Thr68), and Ku70 
before (white bar) or after (black bar) HU treatment. Data are the mean ±SD from 
three samples per group of three independent experiments (*p<0.0001). 
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The elevated levels of these proteins indicate greater DNA damage in KD-HF 
compared to C-HF cells (Figure 37). Ku70 was present in untreated Hep3B, Huh7 
and C-HF cells, whereas Nesprin-1 KD-HF cells had very low levels. Upon HU-
treatment the levels decreased in Hep3B, Huh7 and Nesprin-1 KD-HF. By contrast, 
an increase was seen in Nesprin-1 C-HF (Figure 37A, C). These results indicate a 
defective response in the tumor cell lines and in Nesprin-1 deficient cells and a 
defective recruitment of Ku70 to sites of DNA damage resulting in a failure to protect 
the broken DNA ends from unwanted and excessive nuclease activity which leads to 
misrepair and loss of genetic information. 
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3. Discussion  
The LINC complex is conserved from yeast to mammals and formed by interactions 
between Nesprins and SUN proteins (Libotte et al., 2005; Crisp et al., 2006). 
Nesprins are giant proteins of the LINC complex with a length of 300 nm-500 nm and 
situated in the nuclear envelope. Due to alternative splicing generating proteins with 
differing spectrin repeat copy numbers, there is a great variation in the length of 
Nesprins. Nesprin-1 is one of four Nesprins displaying a pair of connections in a 
molecular chain bridging the nucleus and the cytoskeleton. More specifically, 
Nesprin-1 also contains specific domains to facilitate the integration of the ONM with 
several cytoskeletal structures (Starr and Fridolfsson, 2010; Schneider et al., 2011a). 
Earlier reports indicated that Nesprin-1 C-terminal spectrin repeats interact with 
Lamin and Emerin. On the other hand, these spectrin repeats self-associate to form 
an antiparallel dimer (Mislow et al., 2002a; Zhong et al., 2010). According to our 
findings, N terminal Nesprin-1 spectrin repeats can also self-associate. Moreover, our 
data demonstrate that, presumably with the exception of aa 859-1144, which encode 
spectrin repeats with lower resemblance to the ones of α-actinin, the N-terminal 
spectrin repeats interact with full length Nesprin-1-165. The KASH domain containing 
Nesprin-1 (aa 8034-8749) interact with Nesprin-2, but not with KASH domain lacking 
Nesprin-1 (aa 7938-8644). Notably, these interactions, self-association and 
interaction among the N-terminal spectrin repeats of Nesprin-1 make them ideal 
candidates for maintaining the nuclear architecture. Furthermore, our findings 
suggest that Nesprin-3 mediates recruitment of vimentin to the NE in transfected 
cells.  
Studies with KO mice highlight the biological and functional importance of Nesprin-1.  
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Importantly, mice with C-terminal deletion of SYNE1 including the KASH domain die 
after birth owing to respiratory failure (Puckelwartz et al., 2009). Overall, Nesprin-1 
mutant mice display reduced survival rates, kyphoscoliosis, growth retardation, 
neurogenesis defects, and skeletal and cardiac muscle pathologies (Puckelwartz et 
al., 2009; Zhang et al., 2009; Zhang et al., 2010). Although these findings indicate 
that Nesprin-1 controls several functions, how Nesprin-1 masters all these multiple 
functions is poorly understood. It will be of great interest to determine the specific 
roles of Nesprin-1 on nuclear structure, centrosome, cytoskeleton organization, 
cellular aging, tumorigenesis and genome stability.  
The mechanisms establishing nuclear architecture are not sufficiently known nor are 
the consequences of a deformed nuclear structure for normal cell function unraveled. 
Nuclei of most normal cells have a smooth and ovoid shape, whereas in many cancer 
cells severe nuclear distortions are observed. We studied liver cancer cells and found 
several alterations which we could reproduce by reducing levels of Nesprin-1 by 
knock down in several cells. Most remarkable were the loss of Emerin, an 
upregulation of SUN proteins and changes in the centrosome number and in the 
DDR. Similarly, Zhang et al. reported that Nesprin-1 siRNA knock down in fibroblasts 
affected Emerin localization which correlated with deformed nuclei (Zhang et al., 
2007). From our data we propose that loss of Nesprin-1 is a casual event in 
tumorigenesis in analogy to a recent report showing that Emerin reduction was the 
basis of nuclear morphological deformation and subsequently the cause of 
aneuploidy in ovarian cancer cells (Capo-chichi et al., 2009). 
Deformed nuclear shape and increased size are also SUN1 dependent. Although the 
function of SUN1 and SUN2 in cancer biology is undefined, the finding that SUN1 
accumulation leads to misshapen and enlarged nuclei of HPGS cells is of great 
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significance (Chen et al., 2012). We also noted that brighter SUN1 staining was 
associated with misshapen and enlarged nuclei in Nesprin-1 KD, Hep3B and Huh7 
cells. Furthermore, Zhang and coworkers found an upregulation of SUN1 and SUN2 
in neonatal Nesprin-1-/- cardiac and skeletal muscle, respectively (Zhang et al., 
2010). 
Earlier reports indicated that LINC complex components link the centrosome to the 
nucleus (Salpingidou et al., 2007; Schneider et al., 2011a). In order to elucidate the 
mechanisms behind the centrosome alterations in cancer cells, the effect of a loss of 
Nesprin-1 on centrosome-nucleus distance and centrosome number was determined. 
The centrosome was positioned next to the nucleus in C-HF and C- CH310T1/2 cells. 
In contrast, the centrosome dislodged from the NE in the Nesprin-1 KD-HF, KD- 
CH310T1/2, Hep3B and Huh7 cells, raising the possibility that the Nesprin-1 
deficiency might cause detachment of the centrosome from the NE. Therefore it 
appears that Nesprin-1 plays a significant role in centrosome positioning and number.  
Proteins of the Nesprin family connect the nucleus through their N-termini to the actin 
network (Nesprin-1 and Nesprin-2), the intermediate filament system (Nesprin-3) and 
the microtubule network (Nesprin-2 and Nesprin-4) (Zhen et al., 2002; Padmakumar 
et al., 2004; Wilhelmsen et al., 2005; Roux et al., 2009; Schneider et al., 2011a). 
Extensive F-actin filaments were observed around the nucleus in C-HF and C- 
CH310T1/2 cells whereas the filaments were reduced in KD-HF and KD- CH310T1/2. 
The actin staining was reduced in Hep3B and Huh7 cells possibly due to a decrease 
in Nesprin-1 linkage to F-actin. The microtubule system of Hep3B and Huh7 cells 
was also disorganized. We noted that KD-HF and KD- CH310T1/2 cells displayed 
similar microtubule disorganization. This may also support the previously proposed 
idea that force transmission to the nucleus regulates gene expression by causing 
conformational changes in the DNA structure and by regulating nuclear transport 
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(Wang et al., 2009). As stated earlier, Nesprin-1 mislocalization in HeLa and Swiss 
3T3 cells results in a softer cytoplasm and a damaged connection between the 
nucleus and the cytoskeleton. Therefore, F-actin may cause abnormal cellular 
functions, cytoskeleton network and cancer pathogenesis (Stewart-Hutchinson et al., 
2008).  
The cytoskeleton organization is important for cell migration. Contrary to earlier 
reports and our expectations, cell migration in the Nesprin-1 KD-HF and KD-
CH310T1/2 cells increased significantly compared to C-HF and C-CH310T1/2 cells. 
This is consistent with results obtained for cancer cells like Hep3B, and Huh7 cells, 
where cell velocity was as high as in Nesprin-1 KD-HF and KD- CH310T1/2 cells. 
Earlier studies have suggested that defective nucleo-cytoskeletal connections impair 
the activation of mechanosensitive gene Egr-1 (early growth response factor 1) and 
anti-apoptotic gene iex-1 which are transcription factors (Lammerding et al., 2004; 
Lammerding et al., 2005). Our data demonstrate that in addition to the impaired 
cytoskeleton network, loss of Nesprin-1 also leads to tumorigenesis, indicating that 
Nesprin-1 may suppress several steps in tumorigenesis.  
Cellular senescence has gained significant attention in cancer therapeutic strategies. 
Interestingly, La Porta et al. formulated cancer growth in mathematical terms and 
made predictions for the progress of cellular senescence (La Porta et al., 2012). In a 
related report Collado et al. speculated that senescence markers increase during 
tumor progression (Collado and Serrano, 2010). Cancer stem cells divide forever, by 
contrast, other tumor cells can go into senescence. Senescent cancer cells are not 
only growth arrested but can be also cleared by immune cells (Ventura et al., 2007). 
We have shown here that Nesprin-1 loss also leads to cellular senescence and 
points to the importance of Nesprin-1 in cellular aging. 
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Defects in the DDR network can predispose to cancer and foster cancer progression 
(Clifford et al., 2003; Sherr, 2004). So far, an effect of Nesprin-1 on DNA repair 
mechanisms has not been addressed. Lei et al. reported a reduction of γH2AX and 
phosphorylated Chk1 in SUN1-/-SUN2-/- mouse embryonic fibroblasts and proposed 
an impairment of specific repair pathways (Lei et al., 2012). Our results indicated 
elevated levels of γH2AX, phosphorylated Chk1 and Chk2 in Nesprin-1 KD-HF, 
Hep3B, and Huh7 cells pointing towards overactive pathways which can cause 
chromosomal instability. An integration of Nesprin-1 into the DDR, NER and MMR 
pathways is further supported by its interaction with components of these pathways 
as demonstrated in pull down assays. We identified proteins of the NER (DDB1) and 
MMR (MSH2, MSH6) in pull down experiments using the ABD of Nesprin-1 assigning 
a role to Nesprin-1 isoforms in the NER, and MMR pathway that harbor this domain. 
Furthermore, bioinformatic analysis by Mascia and Karchin led to the proposal of an 
interaction network around Nesprin-1 which contained MSH2 and MSH6 (Masica and 
Karchin, 2011).  
In this study, we focused on the role of Nesprin-1 on the MMR pathway. We found 
that Nesprin-1 interacts not only with MMR proteins MSH2 and MSH6, but also with 
DNA polymerase delta subunit 3 which belongs to the DNA polymerase type-B 
family. Notably, DNA polymerase is required for DNA synthesis and repair. The MMR 
network serves to maintain genome stability (Modrich and Lahue, 1996; Lingle and 
Salisbury, 2001). Its importance is highlighted by participating in a cell-cycle 
checkpoint control system which leads to correction of DNA damage and promotes 
cell-cycle arrest or triggers apoptosis pathways (Kolodner, 1996). Defects in MSH2 
resulted in a greatly increased likelihood of developing certain types of tumors 
(Schofield and Hsieh, 2003). Depending on the type of DNA damage, loss of MMR 
might therefore cause increased mutagenesis, loss of cell-cycle control and 
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resistance to apoptosis (Peters et al., 2003). Based on our results, we speculate that 
Nesprin-1 provides a platform for the association of DNA damage response proteins 
and contributes to the role of the nuclear envelope to generate specific 
subcompartments where damaged DNA is sequestered and comes in contact with 
DNA repair proteins and can be repaired as described for yeast (Figure 38, (Oza et 
al., 2009). 
 
 
Figure 38: Model illustrating Nesprin-1 and MMR interaction. The Nesprin-1 
interaction with the MutSα complex is a constitutive cellular event required for proper 
DNA repair. Therefore, a defect in this interaction chain leads to genome instability. 
 
Functional deficiency of the DDR and the MMR pathway leads to increased genomic 
instability. Based on an altered DDR network in Nesprin-1 deficient cancer cells, 
adequate DDR inhibitors might provide promising methods for selective killing of 
Discussion 
 69 
cancerous cells and improve the efficiency of radiotherapy and chemotherapy. Thus, 
during therapy, cancer cells can be killed by DDR inhibitors whereas the surrounding 
healthy cells can be saved due to their diminished DDR levels. These results can 
open many doors for the development of DDR inhibitors in therapy. 
Since different DNA repair mechanisms exist for certain type of lesions in the 
genome sequence, special proteins are required to initiate repair signaling networks 
for maintaining genome stability. DDB1 functions in the NER machinery by 
participating in the initial steps of DNA repair (Chu et al., 1998; Abbas et al., 2008). 
Our findings suggest that Nesprin-1 interacts with DDB1 in vitro and in vivo. Future 
experiments are needed to elucidate the role of Nesprin-1 in NER signaling. We will 
try to answer these questions: How does Nesprin-1 fit into the picture of NER 
mechanisms and what might be the consequences of Nesprin-1 loss on the NER 
pathway? 
In conclusion, loss of Nesprin-1 triggers an altered cell fate which could lead to 
tumorigenesis. This could be achieved by altered gene expression, altered genome 
stability and an altered nuclear structure. Our data highlight changes in nuclear 
morphology, centrosome positioning, nuclear membrane structure, cytoskeleton 
organization, cellular aging and DNA damage responses upon loss of Nesprin-1. 
Careful evaluation of Nesprin-1 levels may therefore provide novel approaches for 
early disease diagnosis, intervention, and treatment. 
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4. Materials and Methods 
4.1 Materials 
Kits 
M-MLV reverse transcriptase RNase H Minus-kit Promega 
NucleoSpin Extraction Kit     Macherey Nagel 
pGEM-T easy Cloning Kit     Promega 
Pure YieldTM Plasmid System    Promega 
Qiagen RNeasy Mini Kit     Qiagen 
Cell Line Nucleofector Kit V    Amaxa 
 
Enzymes 
Lysozyme       Sigma 
Restriction endonucleases    Life technologies, NEB 
RNAse       Boehringer 
T4 DNA ligase      Boehringer 
Taq polymerase      Boehringer 
Trypsin       Invitrogen 
 
Inhibitors 
Complete mini protease inhibitor cocktail  Sigma 
 
Antibiotics 
Ampicillin       Sigma 
Kanamycin       Sigma 
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Penicillin/Streptomycin     Biochrom 
 
Antibodies 
Primary Antibodies 
Mouse-anti-GFP (K3-184-2)    (Noegel et al., 2004) 
Rat-anti-α-tubulin (YL1/2)     (Kilmartin et al., 1982) 
Rabbit-anti-pAbK1      (Libotte et al., 2005) 
Mouse-anti-LAP2      BD Biosciences 
Rabbit-anti-LMNB1      Abcam 
Rabbit-anti- LMNA/C      Santa Cruz 
Rabbit-anti-Nesprin1 (SpecII)     S.Abraham, Thesis, 2004 
Rabbit-anti-pericentrin      Abcam 
Mouse-anti-emerin (4G5)      Abcam 
Mouse-anti-LAP-2       BD Transduction Laboratories  
Rabbit-anti-SUN1      Abcam  
Rabbit-anti-SUN2      Abcam  
Mouse-anti-NPC      Abcam  
Mouse-anti-phospho-Ser139 H2AX    Millipore  
Mouse-anti-phospho-Ser317 Chk1   Cell Signalling  
Mouse-anti-phospho-Ser345 Chk1   Cell Signalling  
Mouse-anti-phospho-Thr68 Chk2   Cell Signalling  
Mouse-anti-Ku70+Ku80     Abcam  
Rabbit-anti-MSH2       Abcam  
Rabbit-anti-MSH6      Abcam  
Rabbit-anti-DDB1      Abcam 
Mouse-anti-Nesprin-1 (K43-222-2)   (Taranum et al., 2012a) 
Material and Methods 
 72 
Mouse-anti-γ-tubulin      Sigma 
 
Secondary Antibodies 
Anti-mouse IgG, Alexa488-conjugated   Sigma 
Anti-mouse IgG, Alexa568-conjugated   Sigma 
Anti-goat IgG, Alexa568-conjugated   Sigma 
Anti-mouse IgG Alexa Fluor 488    Invitrogen 
Anti-mouse IgG POD      Sigma 
Anti-rabbit IgG POD      Sigma 
Anti-rat IgG POD      Sigma 
 
Bacterial host strains 
E. coli XL1 blue      (Bullock et al., 1987) 
E. coli DH5α       (Hanahan, 1983) 
 
Oligonucleotides 
Nesprin-1-RT-F  CGAACTTTCACAAAATGGATCA 
Nesprin-1-RT-R  TGGTCCACATCAATCCAAGA 
MSH2-RT-F   GGAGAGATTGAATTTAGTGGAAGC 
MSH2-RT-R   TCATTTCCTGAAACTTGGAGAA 
MSH6-RT-F   CATGCGGCGACTGTTCTAT 
MSH6-RT-R   TCATTTCCTGAAACTTGGAGAA 
DDB1-RT-F   TCCAGATCACTTCAGCATCG 
DDB1-RT-R   AGGTGGTCATCAGGATGGAG 
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Media, Buffers and solutions 
10x NCP buffer, pH 8.0 
12.1 g TrisHCl, pH 8.0 (100 mM) 
87.0 g NaCl (1.5 M) 
5.0 ml Tween 20 
2.0 g sodium azide, add H2O to make 1 liter 
 
1x PBS, pH 7.4 
0.2 g KCl (10 mM) 
8.0 g NaCl (10 mM)  
1.15 g Na2HPO4 (16 mM)  
0.2 g KH2PO4 (32 mM) dissolved in 900 ml deionized H2O, adjust to pH 7.4, add H2O 
to make 1 liter, autoclaved. 
 
Gel drying buffer 
EtOH (50%) 
Glycerin (5%) 
Water (45%) 
 
Destaining solution 
EtOH (5%) 
Acetic acid (7%) 
Water (88%) 
 
10 x SDS-PAGE running buffer 
 0.25 M Tris 
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1.9 M Glycine 
1% SDS 
 
4.2 Molecular biological methods 
4.2.1 Primer design 
Fragments of mouse Nesprin-1-165 (Enaptin-165) were PCR amplified with the 
following primers: Nesprin-1-165-1-286 (5′-
GCGAATTCATGGCAACCTCCAGAGCATC-3′ and 5′-
GCGTCGACTTCTGTTGAAACTGGGCCAC-3′), Nesprin-1-165-573-858 (5′-
GCGAATTCAAATTCATGAGTAAGCACTG-3′ and 5′-
GCGTCGACTTAGAGTGTCAAGGATTTCTTAC-3′), Nesprin-1-165-859-1144 (5′-
GCGAATTCATAGAGAAGGGCAGCCAAAG-3′ and 5′-
GCGTCGACTAGCCATTCAATGGGCTC-3′), Nesprin-1-1145-1431 (5′-
GCGAATTCAACCACGACGAGTTAGATATG-3′, and 5′-
GCGTCGACTTAGAAGTGGTGAAGCACATAC-3′) and cloned into the EcoRI/SalI 
site of pGBKT7 (BD Biosciences Clontech, Palo Alto, CA), into pGEX-4T-2 
(Amersham, Piscataway, NJ) or into pEGFP-C vectors (BD Biosciences Clontech). 
Fragments of human Nesprin-1 were PCR amplified with the following primers: 
Nesprin-1-7938-8644 (5′-TCACGTTTTGAAGATTGGCTGAAGTCTTCA-3′ and 5′-
GGGTCTGTGAGTCCCACATCAGGAAGGAGCACC-3′), Nesprin-1-8034-8749 (5′-
CATTTTATTGGCCAGCGTGAGGAGTTTGAG-3′ and 5′-
AGATACACGAATGGCCCTCCTCCACTCTGA-3′ cloned into pEGFP-C vectors (BD 
Biosciences Clontech). 
Nesprin-1 knock down in HF and CH310T1/2 cells was performed by plasmid based 
shRNA (short hairpin RNA) technique. 
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Oligonucleotides were cloned into pSHAG-1 vector using BseRI and BamHI 
restriction sites (Paddison et al., 2002). To knock down Nesprin-1 in HF cells, two 
sets of primers were designed by taking 31 nucleotides from each of exon 6 (5’-
GGATGAAGCGAATCCATGCTGTGGCTAACAT-3’) and exon 143 (5’-
GAAGGAGGTCAGTCGTCATATCAAGGAACTG-3’) of human SYNE1. 
For Nesprin-1 knock down in CH310T1/2 cells, two sets of primers were designed by 
taking 31 nucleotides from each of exon 5 (5’-
GGCTAACATTGGCACCGCACTCAAATTCCTT-3’) and exon 32 (5’-
AGAAGTGGCAGCAGTTTAATTCTGACCTCAA-3’) of murine SYNE1. The 
procedure described in (http://hannonlab.cshl.edu/protocols/BseRI-
BamHI_Strategy.pdf) was used for primer design. 
 
4.2.2 Annealing of oligonucleotides 
To anneal phosphorylated forward and reverse single-stranded oligonucleotides, 9 µl 
forward oligonucleotide (100 mM) and 9 µl reverse oligonucleotide (100 mM) were 
mixed with 9 µl of 10X annealing buffer (100 mM Tris-HCl, pH 8.0, 500 mM NaCl, 70 
mM MgCl2). The mixture of oligos was kept in the boiling water for 5 minutes and 
incubated until the temperature of the water decreased to RT. Annealed oligos were 
diluted in HPLC water with the ratio of 1:60 and ligated into the pSHAG-1 vector 
(Paddison et al., 2002). 
 
4.2.3 Digestion of pSHAG-1 vector 
1 μg of pSHAG-1 vector were linearized using restriction enzymes (BseRI and 
BamHI) that generate overhanging ends compatible with the target sequences. The 
digested product was analyzed by agarose gel electrophoresis.  
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To prevent religation, the 5´-ends of the linearized plasmid were dephosphorylated 
by calf intestinal alkaline phosphatase (CIP). For this, 1-5 μg of the vector (89 µl) 
were incubated with 1 U/µl of CIP (1 µl) adding 10 µl 10XCIP buffer in a 100 μl 
reaction volume (37°C, 30 min). The dephosphorylated vector was purified by the 
High Pure PCR Product Purification Kit (Roche). 
 
4.2.4 Ligation and cloning procedure 
1 μg of linearized and purified pSHAG-1 vector were used for the ligation with 1 µl 
(1:60 diluted) double-stranded oligonucleotides. 4 µl of T4 Ligase buffer, 2 µl of T4 
DNA Ligase (1 U/ μl), and nuclease free water were added to a total volume of 20 µl. 
This reaction was incubated at 15°C overnight and 5 μl of the ligation were mixed 
with competent E. coli XL1 blue. Incubation was conducted for 15 min on ice. The 
cells were shocked by heat exposure at 42°C for 90 s and then incubated 2 min on 
ice. In the next step, 1 ml medium was added to the transformed bacteria followed by 
1 h incubation at 37°C. Finally, 50 μl were spread on LB agar plates containing 
kanamycin (50 mg/ml). The plates were incubated at 37°C overnight.  
Colonies (9-15) were picked and DNA-Mini preparation was performed according to 
Birnboim and Doly (Birnboim and Doly, 1979). Briefly, an overnight culture of single 
clones was centrifuged for 5 min at 5.500 rpm at room temperature (RT). 
Subsequently, the pellet was suspended in 300 µl buffer 1 (50 mM Tris-HCl, pH 8.0, 
10 mM EDTA, 100 µg/ml RNAse A). After addition of buffer 2 (200 mM NaOH, 1% 
SDS), the mixture was incubated for 5 min (RT). The reaction was stopped by adding 
300 µl buffer 3 (3 M KAc, pH 5.5, 1% SDS) and the sample was centrifuged at 
14.000 rpm for 10 min. The supernatant (650 µl) was mixed with 450 µl isopropanol 
and centrifuged again at 14.000 rpm for 20 min to precipitate the DNA. After drying 
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the DNA pellet, it was dissolved with 50 µl Tris-HCl, pH 8.0, and analysed by 
sequencing. 
 
4.2.5 DNA Midi/Maxi preparation 
Correct clones were cultured overnight in 250 ml LB medium containing kanamycin 
(50 mg/ml). Plasmid DNA was isolated using PureYield™ Plasmid Midiprep System 
(Promega). Briefly, 250 ml of an overnight E. coli culture were centrifuged (7000 rpm, 
10 min) and subsequently the pellet was suspended in 6 ml cell suspension solution. 
After the addition of 6 ml cell lysis solution, the mixture was carefully mixed and 
incubated 2 min (RT). For neutralization, 10 ml neutralization solution was incubated 
for 3 minutes (RT), and subsequently centrifuged (10,000 rpm, 15 min). DNA was 
bound to the resin of a binding-column, washed with 5 ml endotoxin removal wash 
followed by a washing step with 20 ml column wash solution and eluted with 300 μl 
nuclease free water. 
 
4.2.6 RNA isolation and cDNA generation for quantitative RT-PCR 
analysis 
For RT-PCR, total RNA was extracted for gene expression analysis using TRIzol 
(Invitrogen). Briefly, the cells were trypsinised and centrifuged in ice cold PBS (1200 
rpm, 5 min). The pellet was suspended in 1 ml TRIzol (50-100 mg cells) and 
incubated for 5 min (RT). Subsequently, the chloroform (for each ml of TRIzol 200 μl) 
was added, mixed and incubated at RT for 2-3 min followed by centrifugation (12,000 
g, 15 min). The aqueous phase was precipitated with isopropanol (for each ml of 
solution 500 μl isopropanol) and incubated for 10 min (RT) and centrifuged (12,000 g, 
10 min). The pellet was washed with 75% ethanol. After a centrifugation step, the 
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pellet was dried and dissolved in RNAse-free water. Finally, the concentration and 
quality of the RNA was determined with the Agilent Bioanalyser (Agilent 
Technologies) and stored at -80°C. 
cDNA was synthesized by reverse transcription of 5 μg RNA with oligo dT18 using 
Superscript II reverse transcriptase (Invitrogen) according to the manufacturer’s 
guide. In brief, 1µg of total RNA was mixed with 2 µl of random primers (pdN6 50 µM, 
Stratagene) and filled up to 15 µl with nuclease free water. After incubation for 5 min 
at 70°C and cooling for 2 min on ice, 5 µl 5x reaction buffer (Promega), 1.25 µl 
dNTP’s (10 mM, Stratagene), 1 µl RNase inhibitor (Rnasin 40 U/µl, Promega), 1.75 µl 
nuclease free water and 1 µl M-MLV-RT (200 U/µl) were added. The samples were 
incubated for 1 h at 37°C and stored at -20°C until use. 
Each sample for real-time RT-PCR analysis contained 200 ng of cDNA, SYBR Green 
Master Mix and 0.4 μM of each primer. The PCR amplification and real-time 
fluorescence detection were performed with the Opticon III instrument (MJ Research) 
using the QuantitectTM SYBR1 green PCR kit (Qiagen). As quantification standard 
defined concentrations of annexinA7 cDNA (Doring et al., 1991) were used for 
amplification. PCR amplification was carried out according to the manufacturer’s 
instruction and all PCR products were amplified in a linear cycle. GAPDH mRNA was 
employed as an internal standard, and each gene expression was determined by RT-
PCR and normalized against GAPDH mRNA levels. All PCR products were amplified 
in a linear cycle. Data are the mean +/-SD from three samples per group of three 
independent experiments. 
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4.3 Protein chemical and immunological methods 
4.3.1 Protein extraction from E.coli and mammalian cells 
E. coli cells were lysed with prokaryotic lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1% Sarcosyl, 1 mM DTT, 1 mM benzamidine, 1 mM PMSF, Proteinase 
Inhibitor Cocktail (PIC, Sigma), and lysozyme). Following 1 h incubation in lysis 
buffer, the cells were sonicated and centrifuged (13.000 g, 4°C, 20 min). For 
incubation with GST-Sepharose 4B, 1% Triton X-100 was added to the lysis buffer. 
Mammalian cells were trypsinised and washed with ice cold 1x phosphate buffered 
saline (PBS) plus protease inhibitor (DTT, Benzamidine and PMSF at 1 mM each). 
After centrifugation at 15,000 rpm at 4°C the pellet was resuspended in lysis buffer 
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% Na-desoxycholate, 
0.1 mM Na3VO4, 0.1% SDS, PIC and protease inhibitors (DTT, Benzamidine and 
PMSF). The sample was denatured in 5x SDS sample buffer at 95°C for 5 minutes. 
The samples were used for SDS-PAGE and western blot analyses. 
 
5 x SDS-Sample buffer 
5 × SDS loading buffer  
2.5 ml 1M Tris-HCl; pH 6.5  
4.0 ml 10% SDS  
2.0 ml Glycerol  
1.0 ml 14.3 M ß-Mercaptoethanol 
200 μl 10% Bromophenol blue 
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4.3.2 Western blotting 
For immunoblotting, equal amounts of total cell protein were separated by SDS-
PAGE (12%, 3%-12% gradient gel). After the SDS page, sheets of Whatman filter 
papers and membranes were pre-cut to the gel dimensions. The Whatman papers, 
sponges, membranes, and gels were also immersed in cold transfer buffer for 5 min. 
For protein transfer, semi-dry or wet blotting transfer was used. Subsequently, the 
membrane was blocked with 12.5 ml 1% blocking solution under constant shaking for 
1 h. After blocking, the membrane was incubated with primary antibody solution for 
either overnight (+4°C) or 1 h (RT). The membrane was washed three times with 
TBS for 15 min. The corresponding appropriate horseradish peroxidase coupled 
secondary antibodies (1:10.000) were incubated for 1 h, and the membrane was 
washed three times with TBS. Antigen-antibody complexes were detected by using 
the ECL western blotting detection solution. The protein bands were visualized using 
X-ray films. After imaging, the membrane was stripped with 0.2 M NaOH for 15 min. 
The stripped membrane was washed twice with TBS for 15 min. After washing the 
membrane, the membrane was blocked with blocking solution for 1 h at room 
temperature and used for antibody incubation. 
 
Transfer buffer SDS-gels   TBS-T 
48 mM Tris-HCl, pH 8.3    15 mM NaCl 
39 mM glycine     1 mM Tris-HCl, pH 8.0  
10% ethanol       0.04% Tween 20 (freshly added) 
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Ponceau staining solution  
2 g Ponceau S  
100 ml 3% Trichloroacetic acid  
0.04% Tween 20 
 
ECL solution 
2 ml 1 M Tris-HCl (pH 8.0) 
200 μl Luminol (0.25 M in DMSO) 3-aminonaphthylhydrazide 
89 μl (0.1 M in DMSO) p-coumaric acid 
18 ml dH2O 
6.3 μl 30% H2O2 
 
Blocking solution 
4% milk-powder in TBS-T 
 
4.3.3 Recombinant protein purification and pull downs 
To identify interaction partners of Nesprin-1, GST-Nesprin-1-286 was used for pull 
down experiments. It encodes the F-actin binding domain of Nesprin-1 (Taranum et 
al., 2012). For pull down assays C2F3 cells were lysed in lysis buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1% NP40, 0.5% sodium desoxycholate, 1 mM DTT, 1 
mM benzamidine, and 1 mM PMSF). For preclearing, lysates of cells were incubated 
with beads for one hour at 4°C followed by incubation with GST-Nesprin-1-286 and 
GST for control. Beads were washed three times with PBS (500 g, 4°C, 1 min) and 
boiled in SDS sample buffer (95°C, 5 min). Samples were separated using 12% SDS 
polyacrylamide gels and stained with Coomassie Brilliant Blue. Protein bands of 
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interest were cut out and subjected to LCMS analysis. To confirm the interactions, 
samples were run using 12% SDS polyacrylamide gels and immunoblotted with a 
rabbit polyclonal MSH2, MSH6, and DDB1 antibody (Abcam). 
 
Coomassie Blue R 250                                               
0,1% Coomassie brilliant blue R 250                             
50% Ethanol  
10% Acetic acid 
 
4.3.4 Co-immunoprecipitation (Co-IP) 
For immunoprecipitation, COS7 cells were transfected with GFP-Nesprin-1-286. The 
untreated and UV treated cells (20 J/m2) were immediately suspended in 1 ml 
hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, and 10 mM KCl, PIC) 
followed by centrifugation (1000 rpm, 20 s, 4°C). Pellets were again resuspended in 
1 ml hypotonic buffer. Cell suspensions were lysed through a needle (0.4 mm) for 10 
times and incubated on ice for 10 min. Nuclear and cytoplasmic fractions were 
separated by centrifugation (1000 rpm, 10 min, 4°C). Pellets (nuclear fraction) were 
washed with 1 ml PBS (1000 rpm, 6x10 min, 4°C). Finally nuclear fractions were pre-
cleared with Protein-A-Sepharose CL-4B (Pharmacia Biotech) for 2 h at 4°C. The 
samples were incubated for 2 h at 4°C with GFP-TRAP beads (ChromoTek). 
Immunocomplexes were washed three times with PBS supplemented with protease 
inhibitors. The samples from pull down and immunoprecipitations were boiled in SDS 
sample buffer (95°C, 5 min) and analyzed by western blot. 
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4.3.5 Immunofluorescence  
Immunofluorescence was done as described (Taranum et al., 2012). The cells were 
grown on 12 mm coverslips and fixed with 3% paraformaldehyde (5 min, RT), 
followed by permeabilization with 0.5% Triton X-100 for 3 minutes (RT). In another 
method for fixation and permeabilization, the cells were incubated with cold methanol 
(-20°C) for 5 minutes. Subsequently, the fixed cells were washed three times with 1X 
PBS and  incubated for 15 minutes with blocking solution (1x PBG: PBS containing 
5% BSA and 0.045% fish gelatine in 1x PBS, pH 7.4). After blocking, primary 
antibodies were diluted in PBG and incubated 1 h (RT) or overnight (4°C). Antibodies 
used were specific for Emerin (4G5, Abcam), LAP-2 (BD Transduction Laboratories), 
Lamin B1 (Abcam), Lamin A/C (StCruz), SUN1 (Abcam), SUN2 (Abcam), mAb414 
recognizing NPC (Abcam), anti-phospho-Ser139 H2AX (Millipore), Ku70 (Abcam), 
MSH2 (Abcam), MSH6 (Abcam), rabbit polyclonal Nesprin-2 pAbK1 (Padmakumar et 
al., 2005), anti-tubulin YL1/2. Nesprin-1 polyclonal antibodies SpecII and mAb K58-
398-2 directed against the C-terminus of human Nesprin-1, affinity-purified rabbit 
anti-Nesprin-1 ABD and mAb K43-322-2 directed against the N-terminus were also 
used (Taranum et al., 2012a). The cells were washed three times for 5 minutes each, 
the samples were incubated for appropriate secondary antibodies conjugated to 
Alexa 488/568 (1:1.000 diluted in PBG) were added for one hour at room 
temperature. Nuclear DNA was stained with 4’,6-Diamidino-2’-phenylindole (DAPI, 
Sigma). Finally the coverslips were mounted on glass slides with gelvatol. Imaging 
was done by confocal laser scanning microscopy (Leica TCS-SP5). Images were 
processed using TCS-SP5 software.  
 
Material and Methods 
 84 
4.4 Cell culture and transfections  
CMT93 (mouse rectum carcinoma), CT26 (murine colorectal carcinoma), WIDR 
(human colorectal carcinoma), CH310T1/2 cells (embryonic mouse mesenchymal 
stem cell line), C2F3 (mouse myoblast), HaCaT (human keratinocyte), HeLa (human 
epithelial carcinoma), Hep3B (human liver cancer) and Huh7 (human hepatocellular 
cancer), DLD-1 (human colorectal carcinoma (Plaschke et al., 2006)) cell lines were 
grown in high glucose Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) 
supplemented with 10% FBS, 2 mM glutamine, and 1% penicillin/streptomycin. 
Primary human dermal fibroblasts (HF) were isolated from foreskin and cultured in 
high glucose DMEM. All cells were grown in a humidified atmosphere containing 5% 
CO2.  
To knock down Nesprin-1, CH310T1/2 cells were transfected twice at intervals of 4 d 
using the Amaxa Nucleofector kit V solution (Lonza). For HF cells, Lipofectamine 
2000 transfection reagent (Invitrogen) was utilized. 
 
Gelvatol PBG (pH 7.4) 
4.8 g Polyvinyl alcohol (87%-89%, Sigma P 8136) 
12 g Glycerol  
Add 12 ml de-ionized water, stir (RT, 10h) 
24 ml 0.2 M Tris-HCl; pH 8.5; stir (50°C, 20-40 min) 
cenrifugation (15 min, 5000 g) 
2.5% Diazabicyclooktan (DABCO)  
Aliquot-storage: – 20°C 
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4.5 Cell biological assays 
4.5.1 Heat stress experiments 
Cells were allowed to attach onto 12 mm glass coverslips for two days before the 
experiment. For heat stress, cells were transferred for heat treatment to a 45°C 
incubator for 30 min. After fixation with cold methanol at -20°C for 5 min cells were 
incubated with monoclonal antibody LAP2 (Abcam) to detect nuclear deformations. 
 
4.5.2 Senescence-associated β-galactosidase  
The cells were seeded in 24-well plates. After a 24 h incubation period, they were 
fixed with 2% formaldehyde, 0.2% glutaraldehye (5 min, RT). Cells were washed 
three times with PBS and incubated at 37°C with freshly prepared senescence-
associated β-Gal (SA-β-Gal) staining solution (1 mg/ml 5-bromo-4-chloro-3-indolyl β-
D-galactoside (X-Gal), 40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium 
ferrocyanide K4Fe(CN)6, 5 mM potassium ferricyanide K3Fe(CN)6, 150 mM NaCl, 2 
mM MgCl2) for 8 h. The cells were imaged using bright field microscopy at 
40xmagnification. 
 
4.5.3 Cell migration assay 
Cell migration was analyzed according to the manufacturer's instructions using an 
Ibidi Culture Insert (Ibidi, Munich, Germany). 100 μl of a cell suspension (4x105 
cells/ml) was applied into each well. After 24 h incubation period at 37°C and 5% 
CO2, the culture insert was removed and the well was filled with serum-supplemented 
normal growth medium (300 μl of cell media). Cell migration into the wounded area 
was monitored using a Leica CTR7000 HS (10x0.3 objective). Images were captured 
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at various time points and the cell velocity was calculated by Image J. Experiments 
were repeated at least thrice for each cell type. 
 
4.5.4 DDR assays 
To assay for DNA damage response, the cells were grown for 24 h in 500 μM 
hydroxyurea (HU) or taken after 20 J/m2 UV (Hajdu et al., 2011). The HU treated 
cells were processed for immunofluorescence and western blot analysis, UV 
exposed cells were processed for immunofluorescence.  
Cell synchronization was performed according to a recent study (Li et al., 2013). In 
brief, cells were arrested at G1/S by culturing for 18 h in 2 mM thymidine-containing 
medium, and then for 10 h in thymidine-free medium. Subsequently, cells were 
incubated with complete medium containing thymidine for an additional 15 h before 
release into complete medium. Finally, cells were harvested at 0 h (G1 phase), 1 h 
(early S), 2.5 h (middle S), 4 h (late S), and 8 h (G2/M). The cell-cycle status was 
confirmed by flow cytometry. FACS cell sorting was carried out at the central facilities 
of the CMMC. 
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